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The high mortality rate of cancer worldwide was the impetus for this research project. Our aim was to 
synthesize suitable radiopharmaceuticals that could potentially act as anti-cancer imaging agents. This 
entails the synthesis of novel cyclic-cored dendrimers as well as their functionalization at the peripheries, 
in order to promote selective interaction with hydroxyapatite (HAp), which is a common target for bone 
cancer imaging agents. These dendritic ligands should also be able to act as a scaffold for “cold” 
radiopharmaceutical analogues.  
Dendrimers exhibit different physicochemical behavior based on their constituents, thus 1,4,8,11-
tetraazacyclotetradecane (cyclam) and 1,4,7-triazacyclononane (TACN) were chosen as core molecules to 
alter the overall topology of the macromolecule. Several attempts describing the synthesis of cyclam-cored 
poly(amidoamine) (PAMAM) dendrimers, TACN-cored PAMAM dendrimers as well as cyclam-cored 
polypropylenimine (PPI) and cyclam-cored benzyl amine (BA) dendrimers is reported. During the 
PAMAM dendrimer (D1 - D6) synthesis some complications during the amidation step prohibited us from 
acquiring higher generation dendrimers, thus the alternative PPI and BA branched dendrimers (D7 - D10) 
were chosen in order to compare the effect of the various dendrimers employed. The latter goes via a nitrile 
intermediate followed by reduction to afford primary amine terminated dendrimers, but complete nitrile 
reduction eluded us.  
Generation 1 cyclam-cored PAMAM dendrimers (D2) was identified as a viable candidate to functionalize 
with either phosphonic acid or salicylaldimine chelators. The phosphonic acid analogue (L1) was obtained 
via an Irani-Moedritzer reaction and using similar reaction conditions a set of model ligands based on propyl 
amine (ML1 - ML2) and commercial diaminobutane (DAB) PPI dendrimer (L2) was synthesized for 
comparison with the multinuclear derivative. The ligands were usually hygroscopic in nature and under the 
employed reaction conditions the internal amide of PAMAM showed some evidence of hydrolysis. Two 
gallium (III) complexes (C1 and MC1) was isolated from L1 and ML1. Alternatively, the analogous 
salicylaldimine ligand (L3) was synthesized via a Schiff base condensation reaction. The relative simplistic 
ligand was used to isolate two gallium (III) complexes (C4a and C4b) as well as a copper (II) complex 
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(C5). These compounds were characterized by a range of analytical techniques (FT IR, UV Vis and NMR 
spectroscopy, mass spectrometry and elemental analysis).  
The salicylaldimine analogue (L3) as well as the gallium (C4a and C4b) and copper (C5) derivatives were 
subjected to preliminary DNA binding studies via UV vis spectroscopy titration experiments. L3 and C4b 
exhibited hyperchromism suggestive of groove binding interaction with DNA. On the other hand, C5 
displayed a hypochromic effect implying intercalation as the mode of binding with DNA. Surprisingly C4a 
showed varying hyper- and hypochromic effect insinuating various binding modes contribute as it interacts 
with DNA. The DNA binding studies preliminarily indicate that these compounds interact with the DNA 
structure, meaning it has good potential as anti-cancer agents.  
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Die hoë sterftesyfer van kanker wêreldwyd, was die dryfkrag agter hierdie navorsingsprojek. Ons doel was 
om geskikte radiofarmaseutiese molekules te sintetiseer wat moontlik as anti-kanker beeldings-agente kan 
optree. Dit behels die sintese van nuwe sikliese-kern dendrimere asook die funksionalisering van hul 
oppervlak groepe om selektiewe interaksie met hidroksieapatiet (HAp) te bevorder, wat 'n algemene teiken 
vir beeldings-agente vir beenkanker is. Hierdie dendritiese ligande moet ook as 'n steier vir "koue" 
radiofarmaseutiese analoëe kan funksioneer. 
Dendrimere vertoon verskillende fisiese en chemiese gedrag gebaseer op hul bestandele, dus was 1,4,8,11-
tetrasasiklotetradekaan (siklam) en 1,4,7-triazasiklononaan (TACN) gekies as kernmolekules om die 
algehele topologie van die makromolekule te verander. Verskeie sintetiese pogings wat die gebruik van 
siklam-kern poliamidoamien (PAMAM) dendrimere, TACN-kern PAMAM-dendrimere asook siklam-kern 
polipropyleenimien (PPI) en siklam-kern bensielamien (BA) dendrimere, word aangemeld. Tydens die 
syntese van die PAMAM dendrimere (D1 - D6) het sommige komplikasies tydens die amidasiestap ons 
verbied om hoër generasie dendrimere te isoleer, dus is die alternatiewe PPI- en BA-vertakte dendrimerers 
(D7 - D10) gekies om die verskillende dendrimere te vergelyk. Laasgenoemde gaan via 'n nitriel 
intermediêr, gevolg deur reduksie wat dendrimere met primêre amien groepe op die periferie bied, maar 
volledige nitril reduksie het ons ontwyk. 
Generasie 1 siklam-kern PAMAM-dendrimere (D2) is as 'n geldige kandidaat geïdentifiseer om te 
funksionaliseer met fosfonsuur of salisielaldimien. Die fosfonsuur analoog (L1) is verkry via 'n Irani-
Moedritzer reaksie. Deur soortgelyke reaksietoestande toe te pas, was 'n stel model ligande gebaseer op 
propielamien (ML1-ML2) en kommersiële diaminobutaan (DAB) PPI-dendrimer (L2) gesintetiseer vir 
vergelyking met L1. Die ligande was gewoonlik higroskopies van aard en onder die reaksietoestande het 
die interne amied van PAMAM bewyse van hidrolise getoon. Twee galium (III) komplekse (C1 en MC1) 
is van L1 en ML1 geïsoleer. Die salisielaldimien-analoog (L3) was gesintetiseer via 'n Schiff-basis 
kondensasie reaksie. Die ligand was gebruik om twee galium (III) komplekse (C4a en C4b), sowel as 'n 
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koper (II) kompleks (C5) te isoleer. Die bogenoemde molekules was gekaraktiseer deur 'n verskeidenheid 
analitiese tegnieke (FT IR, UV Vis en NMR spektroskopie, massaspektrometrie en elementêre analiese). 
Die salisielaldimien analoog (L3) sowel as die galium (C4a en C4b) en koper (C5) afgeleides was 
onderworpe aan voorlopige DNA bindings studies via UV/Vis spektroskopie titrasie eksperimente. L3 en 
C4b het hiperchromie vertoon wat dui op groef bindende interaksie met DNA. Aan die ander kant het C5 
'n hipochromiese effek vertoon wat interkalasie impliseer as die manier van bind met DNA. Verbasend 
genoeg toon C4a wisselende hiper- en hipochromiese effekte, wat insinueer dat daar verskillende 
bindingswyses bydra tot die interaksie met DNA. Die DNA bindende studies dui voorlopig aan dat hierdie 
molekules met DNA bind, en dat dit goeie potensiaal as anti-kanker agente het.   
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1 Dendrimers as targeted Radiopharmaceuticals for Cancer Diagnosis 
1.1 Introduction 
The earliest written description of cancer dates back to approximately 3000 BC in which the Edwin 
Smith papyrus describes a case of breast cancer that was incurable. The Ebers papyrus dates back to 1500 
BC and contains records of skin, uterus, stomach and rectum cancers.1 The Greek physician, Hippocrates 
(460 – 370 BC), discarded the superstitious belief surrounding cancer and postulated that cancer was caused 
by an imbalance of body secretions (blood, mucus, bile). The growth of cancer reminded Hippocrates of a 
crab and he used the words ‘carcinos’ and ‘carcinoma’ to describe tumors, which refer to crab in Greek. 
Aulus Celsus (25 BC-AD 50) translated these Greek words to Latin from which the term cancer originated 
and has been used until the present day. Claudius Galen (130 – 200 AD) proposed that black bile caused 
incurable cancer, whereas yellow bile was the cause for curable cancer. He used the term ‘oncos’ to describe 
tumors, thus the study and specialization of cancer are referred to as oncology.2 Religious restrictions 
severely hampered the advancement of medical knowledge and more than 1000 years passed before Galen’s 
theory was rejected. Only once scientists performed autopsies where they able to disprove the existence of 
black bile. During the 16th century, Paracelsus (1493 – 1541) studied tumors of several mine workers and 
correlated cancer to chemical exposure of the work environment.2 He was first to administer chemicals 
(mercury, lead, sulfur, iron, zinc, copper, arsenic, iodine, and potassium) for the treatment of cancer, 
however this cost him his life after his challengers beat him to death in Salzburg, Austria.3 Percival Pott 
(1714 – 1788) noted the correlation between chimney sweeps and cancer of the scrotum due to chronic 
exposure to soot.4 During the 18th century Giovanni Morgagni steered oncology in a more scientific 
direction by relating patient’s illness to pathological findings while performing biopsies. However it was 
not until the 19th century, with the assistance of the microscope, that Rudolf Virchow (1821 – 1902) 
propelled the field of oncology to the micro-level by relating microscopic pathology to illness. He claimed 
that cancer was a disease of cells, while David Hansemann (1790 – 1864) proposed that tumor cells have 
some abnormal chromatin content.2 Early 20th century saw Theodore Boveri (1862 – 1915) present his 
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theory of cancer based on the abnormalities of chromosomes.5 The work Boveri did is considered the 
cornerstone of modern molecular approaches to cancer. Shortly after this transition of understanding to a 
molecular scale, Ellerman and Bang6 as well as Peyton Rous7 reported on independent research relating to 
tumor viruses in chickens. Ellerman and Bang reported on inducing leukemia in healthy chickens in 1908, 
but it was only until Peyton Rous was able to isolate a section of a sarcoma present in the breast muscles of 
hens in 1910 that the first RNA tumor virus was discovered. He received a Nobel Prize for his work in 
1968. In 1915 Katsusaburo Yamagiwa and Koichi Ichikawa8  were able to prove that cancer can be induced 
using coal tar on rabbit skin, a similar effect to what tobacco is responsible for. However it was not until 
James Watson and Francis Crick discovered the exact structure of DNA, for which they received a Nobel 
prize in 1962,9,2 that a shift to molecular level was truly possible. All cellular function is dictated by DNA 
and once the code was interpreted, modern techniques to answer complex chemical and biological questions 
became a possibility. 
Today cancer is regarded as the leading cause of death worldwide. According to the World Health 
Organization (WHO), the disease is responsible for 8.2 million deaths and 14.1 million new cases were 
reported in 2012.10 This high mortality rate justify the need to further scientific and technological 
advancement that address the issues concerning cancer. The “magic bullet” concept postulated by Paul 
Ehrlich in the early 1900’s laid the cornerstone for modern day target-selective research. Targeted drug 
delivery is based on the selective interaction between a biomolecule and a specific moiety present at the 
target site. Research has developed to the extent that conventional treatment methods (surgery, chemo- and 
radiotherapy) in combination with innovative modalities, provide a realistic approach to addressing the 
challenges faced today. Recent developments address the interdependence between the targeting moiety, 
the carrier and the drug. Continuing along this thought, this review intends to cover literature pertaining to 
the use of dendrimer macromolecules as scaffolds for radionuclide used as diagnostic imaging modules for 
bone cancer.  
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1.1.1 Targeted Cancer Treatment 
Ongoing research devoted to the complex origin and intricate nature of cancer has identified several 
aspects that aid in selective drug intervention. Conventional chemotherapeutic drugs have shown promise, 
but their efficacy are governed by pharmacokinetic- (how the body allows the drug molecule to move into, 
through- and out of the body) and pharmacodynamic (the effect the drug molecule has on the body and how 
it interacts with tumor cells) profiles. Generally, low drug solubility, unselective accumulation and 
premature clearance, hamper chemotherapeutics. More recently, the ability that the disease possesses to 
develop its own offense via various resistance mechanisms,11 as well as the unique responses illustrated by 
different patients, has warranted urgent attention. In order to develop a targeted drug delivery system 
(TDDS), it is important to understand the biological path that the intended system has to pass through to 
reach its target site.  
1.1.1.1 Bone Structure  
The bone matrix acts as the supporting structure of our body and consists of 69 % inorganic, of which 
99 % is hydroxyapatite (HAp), and 22 % organic components of which 90 % is collagen.12 The specific 
shape, size, and structural integrity are constantly regulated via bone modeling and -remodeling processes. 
Bone modeling is the process involved in forming bone from cartilage. During bone modeling, the 
formation and resorption of bone occur independently at separate environments and governs the 
morphology and mass acquired during growth. Bone remodeling can be thought of as the maintenance 
process during which old bone is continuously removed and replaced by new bone. Bone remodeling 
maintains the structural quality and regulates the mineral metastasis (calcium and phosphate).12  
Two important cells that participate in bone remodeling are osteoclasts and osteoblasts. The osteoclasts 
cells are responsible for breaking down the bone tissue, whereas osteoblasts cell specialize in forming new 
bone. For bone remodeling, these two types of cells interact and are synchronized to work in unison as basic 
multicellular units (BMUs). Several proteins have been identified to be involved during the five-step 
remodeling process that can cause an imbalance between bone forming and bone resorbing. One such 
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example is the parathyroid hormone (PTH) which maintains calcium homeostasis and induces osteoblast to 
express monocyte chemo-attractant protein-1 (MCP-1), colony-stimulating factor 1 (CSF-1) and receptor 
activator of NF-КB ligand (RANKL). These promote osteoclast formation, which during the resorption 
phase, release HCl and cathepsin K (Cat K) that dissolves the organic matrix. The matrix debris is removed 
by tissue macrophages, known as osteomacs, residing in periosteum and endosteum. These osteomacs work 
in tandem with the mesenchymal bone-lining cells that possess the ability to deposit the fibrous protein 
constituent of bone (collagenous matrix). The coupling signal that initiates the transition from bone 
resorption to bone formation was initially thought to be stored in the bone matrix itself and other hypotheses 
were that the osteoclasts store the signals. Although it is unknown how the formation phase is activated, 
the process involves the recruitment of osteoblast precursors at the Howship lacunae. Once the osteoblast 
precursors have developed and are in place, they proceed to synthesize bone matrix known as osteoid. They 
are also responsible for subsequent mineralization by HAp. The process of bone remodeling concludes once 
the amount of bone formed is equal to that removed. During the final termination phase, the osteoblast can 
either form part of the bone-lining cells, undergo apoptosis or become embedded in the matrix and 
differentiate into osteocytes.  
Osteoporosis occurs once the bone resorbing process outweighs the bone forming process, thus 
creating bone with inadequate strength. Other imbalances in bone turnover include osteosarcoma which 
describes osteoblastic differentiation due to malignant osteoid and bone metastasis. During the bone 
remodeling process, there are several properties, especially the environment offered by HAp, that can be 
exploited to improve diagnosis and treatment of bone cancers and overcome drug delivery challenges.9  
1.1.1.2 Tumor Growth and Microenvironment 
The microenvironment surrounding cancerous cells can be best understood when looking at the 
tumor growth. Generally, the nature of cell growth can be traced back to oncogenes and tumor suppressor 
cells.13 The former acts as activators, whereas the latter is concerned with inhibiting specific processes. 
Normal cells initially proliferate to encourage growth, but eventually, they serve as regulators that replace 
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old or damaged cells. Tumor cells proliferate uncontrollably in a disordered fashion. The rapid rate at which 
tumor cells proliferate allows them to displace normal cells and consume most of the available nutrients. 
Initially, diffusion of nutrients is sufficient to sustain the growth of tumor cells, but only up to a size limit 
of ± 2 mm.3 In order to grow past this limit, they need to acquire new blood vessels. They do so through a 
process known as angiogenesis whereby new blood vessels form from pre-existing vessels (Figure 1.1). 
 
Figure 1.1: Angiogenesis: Formation of new blood vessels with sufficient nutrients to sustain the rapid tumor growth. 14 
The rapid proliferation observed in tumor cells restricts proper vasculature development and is 
responsible for its disordered and fenestrated nature. The incomplete development of the endothelial (a 
monolayer that covers vasculature and lymphatic systems) leads to improper basement membranes and 
leaky endothelium linings with pores ranging from 200 nm-2 µm.15 The rapid proliferation rate also 
compromises the development of the lymphatic system which regulates waste in the interstitial 
space/extracellular space.16 As a result of the porous aberrant vasculature and lack of circulation, the blood 
flow and the interstitial fluid pressure fluctuate. Inefficient blood flow promotes the formation of hypoxic 
and acidic conditions in tumor cells which influence tumor progression, metathesis and the development of 
multi-drug resistance.17 Alternative methods to alleviate blood flow restrictions has been investigated.18 
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The disordered/abnormal nature encountered in cancer cells accounts for its non-uniform heterogeneity.19 
The leaky nature increases the interstitial fluid pressure which prohibits convection/diffusion of molecules 
through the vascular and interstitial spaces.20  
 
Figure 1.2: General tumor microenvironment. 21 
1.1.1.3 General Targeting Strategies 
Several physiological conditions of the microenvironment have been identified as potential targeting 
strategies. The abnormal vasculature has illustrated different retention profiles based on the phenomenon 
known as the enhanced permeability effect (EPR).22 It describes how molecules with discrete 
physicochemical properties can enter the porous, highly permeable blood vessels available in tumor cells 
and display extended retention profiles. This enables the selective accumulation of drug molecules, thus 
addressing the non-specific nature of drug molecules and reducing severe side effects. The idea to alter the 
pharmacokinetics and biodistribution of a compound by exploiting the pathophysiological characteristics 
of the tumor vascular is known as passive targeting. The strategy does, however, depend on the tumor 
heterogeneity and the nature of the extracellular matrices, coupled with high interstitial fluid pressure 
prohibiting diffusion. 
Alternatively, the active targeting strategy relies on the pharmacodynamics and selectivity of the drug 
compound. Essentially, the drug is modified to incorporate a modality that ideally shows selective 
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interaction with overexpressed cancer cells. These drug-conjugates are aimed to improve selective bio-
distribution; however if not carefully designed, they can lead to non-specific binding and receptor-mediated 
endocytosis which can cause an increase in drug toxicity and a decrease in effective drug dosage.23  
 
Figure 1.3: Targeting strategies. 24 
Current research tends to combine passive and active targeting strategies and since the late 1970’s drug-
conjugates capable of responding to subtle stimuli have been investigated.25 Stimuli-responsive drug 
delivery goes beyond active and passive targeting, counting on a combination of physical, chemical and/or 
biological aspects that may ultimately lead to the triggered release of drugs-conjugates. These triggers are 
categorized as external (temperature, light, ultrasound, magnetic force, electric fields) or internal (pH, 
redox, enzyme) mediated stimuli. 
External stimuli usually rely on some form of physical trigger applied externally. Amongst the most 
common methods are thermoresponsive systems which rely on a change in temperature to induce some 
change in the TDDS. Needham et al.26 utilized local hyperthermia (temperature increase) to enhance the 
permeability of their lipid bilayer to encourage desorption of encapsulated drugs. At elevated temperature 
the increased vascular permeability allows the desorbed molecule to penetrate deep into the tumor. Light 
offers a non-invasive, simplistic and biocompatible approach that promises precise control over spatial 
exposure as a stimuli,24 but can only be used on regions that can be directly illuminated due to significant 
light scattering by soft tissue.27 It is well known that the azobenzene moiety isomerizes in a reversible 
fashion under irradiation of ultraviolet-visible light,28 which could aid in the triggered release of 
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encapsulated drug molecules.29 Ultrasound destabilizes nanocarriers based on the cavitation phenomenon. 
Essentially vapor cavities are formed in liquid and once subjected to ultrasound waves disrupts nanocarriers 
to promote drug release and momentarily increase its permeability. Azagury et al.30 reported on transdermal 
drug delivery using ultrasound. Magnetic fields and electric fields are alternative external stimuli used to 
promote controlled drug release. The former can guide paramagnetic nanoparticles to the desired area 
induce drug release based on a hyperthermic effect and the latter can guide conducting nanoparticles before 
promoting drug release by electrochemical reduction-oxidation.27 
Internal stimuli largely rely on the microenvironment surrounding tumor cells and exploit subtle changes 
to induce drug delivery. The irregular angiogenesis of tumor cells causes a deficit of nutrients and oxygen. 
This leads to a microenvironment that is slightly more acidic and rich in reducing agents. The difference in 
pH between healthy cells (~7.4) and the extracellular environment of tumor cells (6.5-7.2) can be utilized 
as a trigger for drug delivery. The development of nanocarriers that possess ionizable groups or acid 
sensitive bonds is ideal properties to exploit the acidic microenvironment. Ionizable groups are subject to 
conformational and solubility changes, whereas acid sensitive bonds can be cleaved to encourage drug 
delivery.31 The regulatory glutathione tripeptide responsible for the cellular reductive microenvironment is 
overexpressed in tumor cells and can be exploited during triggered drug delivery. Wen et al.32 reviews drug 
carriers with redox sensitive disulfide bond susceptible to cleavage for intracellular drug delivery. Although 
not as common, enzyme-based stimuli can also be harnessed to improve drug delivery. The design of drug 
carriers with short peptide sequences as linkers can be cleaved by enzymes such as proteases, 
phospholipases or glycosidases typically found in the extracellular environment of tumor in order to aid the 
release of drug molecules.24 
The complex nature of cancer requires innovative methods to combine targeted delivery with stimuli-
responsive systems. However, developing a module that combines the aforementioned targeting strategies 
is a complex process, especially relating physical and chemical features to specific microenvironment 
aspects. The term theranostics has been used to describe vessels capable of combining diagnostic and 
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therapeutic strategies which can perform several functions such as multi-stimuli-responsive, multi-targeted 
delivery and co-delivery of drugs simultaneously in a controlled and targeted manner. Theranostics can 
monitor the accumulation of nano-medicine compounds at the target site, visualize biodistribution, quantify 
triggered drug release, and assess therapeutic efficacy. Theranostics strives to shift the frontier of 
biomedical development to the stage of personalized medicine.  
1.1.2 Targeted Radiopharmaceuticals  
A carefully designed TDDS can provide protected transport of drugs, enhanced targeting abilities and a 
manner of control during drug release. The development of nanotherapeutics that increase the 
bioavailability of hydrophilic drug molecules, bypass biodegrading enzymes, release the cargo at the 
affected site upon small changes in stimuli and degradation or excretion of the carrier molecule offers 
immense prospects to improve the efficacy of drug delivery and to limit the side effects of anti-cancer drugs. 
Given the broad understanding of the tumor microenvironment relating to bone cancer and the knowledge 
of the possible targeting strategies available, the focus will now shift to the individual components that 
combine to construct a TDDS, in particular target-specific radiopharmaceutical as radiotherapy has shown 
promise in cancer diagnosis and therapy.  
During the design of a target-specific radiopharmaceutical, it is important to know which isotope to use 
in line with the intended application (diagnostic or therapeutic). The choice of radioisotope would govern 
the choice of chelating ligand, usually bifunctional chelators. Ideally, radiopharmaceuticals require a 
kinetically inert, thermodynamically stable complex to reduce side effects and increase or maintain its 
efficiency. These ligands are usually coupled to specific biomolecules to alter their solution properties and 
improve their selectivity. In some cases, a linker molecule in-between the biomolecule and ligand aid in the 
degradation of the TDDS in order to increase excretion rates (Figure 1.4).  
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Figure 1.4: Four building blocks of TDDS. 
1.1.2.1 Properties of Common Radionuclides  
In 1913, George de Harvesy first postulated the “tracer principle”, which is the basis of modern day 
radiopharmaceuticals. The principle essentially entails the use of a radionuclide-conjugate to trace its 
distribution.33 Radiotherapy relies on particles which the radioactive isotopes emit as it decays. Radiation 
therapy can be divided into three categories: external radiation, internal radiation or systemic radiation. 
External radiation delivers high-energy x-rays; electrons or proton beams from the outside of the body. 
Internal radiation places radiation sources, temporarily or permanently, within or near the tumor slowly 
releasing radiation as the source decays. Systemic radiation delivers radionuclide-conjugates known as 
radiopharmaceuticals through the bloodstream either by ingestion, catheter infusion or intravenous 
administration. 
When considering which isotope to select for the TDDS it is important to know the intended 
application. For therapeutic pharmaceuticals particles that cause ionization through its decay to induce cell 
death are used. α-, β- and auger-emitting radionuclides emits radiation energy able to destroy or damage 
DNA directly or indirectly by creating free radicals within the cells that damage the DNA. Linear energy 
transfer (LET) is the term used to describe the amount of energy an ionizing particle transfers to the material 
traversed per unit length and is generally expressed in kiloelectronvolts per micrometer (KeV/µm). Typical 
α-emitters such as Astatine-211 (211At), Bismuth-212 (212Bi), Bismuth-213 (213Bi), Actinium-225 (225Ac), 
Radium-223 (223Ra), Lead-212 (212Pb), Thorium-227 (227Th), and Terbium-149 (149Tb) eject high energy 
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with quite short ejection range.34 Cell death occurs only when α-particles traverse the cell nucleus, thus they 
are ideal for small tumors. β-emitters such as yttrium-90 (90Y), iodine-131 (131I), lutetium-177 (177Lu), 
samarium-153 (153Sm), strontium-89 (89Sr), holmium-166 (166Ho), rhenium-186 (186Re), rhenium-188 
(188Re), copper-67 (67Cu), promethium-149 (149Pm), gold-199 (199Au) and rhodium-105 (105Rh) have lower 
LET and longer radiation ranges relative to α-emitters.34 They can damage or kill cells by indirect damage 
known as the “crossfire effect”. β-emitters can overcome treatment resistance and are mostly used for large 
tumors. Auger-emitters such as bromine-77 (77Br), indium-111 (111In), iodine-123 (123I), and iodine-125 
(125I) are low in energy with short range which arise during the decay of the radioisotope.35 During the 
decay, vacancies formed in the inner shell due to electron capture or internal conversion is rapidly filled by 
electrons undergoing relaxation in from higher energy shells. These transitions emit a characteristic 
Auger.36 
For diagnostic pharmaceuticals, the radionuclide should be either a gamma- (67Ga, 99mTc, 111In, 177Lu) 
or positron (68Ga, 64Cu, 44Sc, 86Y, 89Zr) emitter. The purpose of diagnostic radiopharmaceuticals is to 
provide an accurate molecular morphological description of the target location, but also provide an ideal 
opportunity to evaluate several biological functions such as bio-distribution and excretion rates.37 
Diagnostic radiopharmaceuticals utilize radionuclides that decay to release photons with high enough 
energy to penetrate the body and be detected externally but low enough to be collimated by a camera. 
Diagnostic radiopharmaceuticals require a radionuclide that decays solely by photon emission as any 
release of additional particles would administer undesired extra dose to the patient. The most common 
imaging modality used in diagnostic radiopharmacy to assess the molecular morphology is single positron 
emission computed tomography (SPECT). This method requires a gamma-emitting isotope. Positron 
emission tomography (PET) is another common imaging modality that requires positron-emitting 
isotopes.33  
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Properties such as half-life, type of radiation energy and presence or lack of other particulate radiation 
emissions determines the suitability of a radionuclide for a specific application. (Table 1.1) below 
summarizes the properties of some common radionuclide. 
Table 1.1: Properties of common Radionuclides, EC = electron capture. 38,39 
Nuclide t1/2 (h) Decay mode E (keV) Nuclide 
t1/2 
(h) 
Decay 
mode 
E (keV) 
60Cu 0.4 
β+ (93%) 
EC (7%) 
β+  
3920, 3000, 2000 
212Pb 10.6 β - (100%) 
α  
570 
61Cu 3.3 
β + (62%) 
EC (38%) 
β+  
1220, 1150, 940, 560 
225Ac 240 α (100%) 
α  
5600-5830 
62Cu 0.16 
β + (98%) 
EC (2%) 
β+  
2910 
123I 13.2 γ 
γ  
159 
64Cu 12.7 
β + (19%) 
EC (41%)  
β - (40%) 
β+  
656 
131I 202 
γ (81.2%) 
β 
γ  
284, 364, 637 
66Ga 9.5 
β + (56%) 
EC (44%) 
β+  
4150, 935 
99mTc 6.0 γ 
γ  
140 
67Ga 78.2 EC (100%) 
γ 
93, 184, 300 
18F 1.83 Positron 640 
68Ga 1.1 
β + (90%) 
EC (10%) 
β+  
1880 
11C 20.4 Positron 960 
44Sc 3.9 
β + (94%) 
EC (6%) 
γ  
1157 
β+  
1474 
13N 9.96 Positron 1190 
47Sc 80.2 β - (100%) 
γ  
159 
β-  
441, 600 
15O 2.07 Positron 1720 
111In 67.2 EC (100%) 
γ  
245, 172 
186Re 89.2 
γ  
β (9.4%) 
β  
1069 
177Lu 159.4 β - (93%) 
γ 
122, 208 
β-  
177, 385, 
498 
188Re 17.0 
γ  
β (15.1%) 
β  
2120 
86Y 14.7 
β + (33%) 
EC (66%) 
β+ 
1221 
166Ho 26.9 
γ  
β (6.7%) 
β  
1853 
90Y 64.1 β - (100%) 
β-  
2280 
89Sr 52.7 d Β 
β  
1463 
89Zr 78.5 
β + (23%) 
EC (77%) 
β+  
897 
32P 14.3 d β 
β  
1710 
212Bi 1.1 
α (36%) 
β - (64%) 
α  
6050 
β-  
6089 
221At 7.2 α 
α  
5869 
213Bi 0.76 
α (2.2%) 
β - (97.8%) 
α  
5549 
β-  
5869 
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The ionization particles ideal for diagnostic and therapeutic purposes usually differ. Thus, the 
combination of diagnostic and therapeutic radionuclides into a single modality is a relatively new, complex 
concept. Different radionuclides emitting different ionization usually cause harmful additional radiation. 
Additionally, different radionuclides react differently with specific chelators which complicate the 
synthesis of such theranostic molecules.  
Müller et al. used 4 different isotopes of terbium (149Tb, 152Tb, 155Tb and 161Tb) to form 4 complexes 
using the same type of ligand, but each for a specific application. 152Tb-cm09 and 155Tb-cm09 are ideal for 
PET and SPECT diagnosis, respectively. 149Tb-cm09 and 161Tb-cm09 emit α- and β-particles, respectively, 
which is ideal for therapy. This proof of concept illustrates that it is possible to combine diagnosis and 
therapy in a single module by using the different isotopes of the same element (Figure 1.5).40 
 
Figure 1.5: Terbium-cm09 complexes: black -  folic acid as targeting agent; blue -  albumin-binding entity to prolong 
blood circulation time; red - terbium radioisotope stably coordinated by a DOTA chelator. 40  
Copper has a variety of radioactive isotopes available (60Cu, 61Cu, 62Cu, 64Cu and 67Cu) and display 
diverse coordination chemistry with soft donor atoms (phosphorous and sulfur). Copper-64 is a unique 
radioisotope that decays via positron- and β-emission (39 %) useful for diagnostic imaging (PET) and via 
electron capture decay (43 %) ideal for therapeutic radiopharmacy.41 The use of macrocyclic ligands for 
copper labeling generally affords more stable complexes relative to acyclic ligands.42 Initially, cyclen and 
cyclam were considered, but it was found that their respective acetic acid analogues 1,4,7,10-
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tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and 1,4,8,11- tetraazacyclotetradecane-1,4,8,11-
tetraacetic acid (TETA) showed increased in-vivo stability.43 A further increase in the kinetic stability was 
achieved by using cross-bridged derivatives of TETA; however, harsh radiolabeling conditions are required 
for these analogues.44,45 The use of 1,4,7-triazacyclononane-1,4,7- triacetic acid (NOTA) has recently drawn 
attention due to its mild radiolabeling conditions and enhanced in-vivo stability.46,47  
One of the most widely used nuclides for imaging is 99mTc due to its properties and relative ease of 
preparation. Several examples illustrating the use of stable 99mTc-phosphonate complexes with high affinity 
for diseased bones as diagnostic imaging agents for SPECT.48–51 PET gives higher resolution and sensitivity, 
thus gallium-68 radioisotope has been probed as an alternative. The most common oxidation state of 
gallium (III) prefers hard donors such as nitrogen or oxygen donors as a consequence of their high charge 
density. These metals prefer to form six coordinated complexes due to their small size. These highly charged 
cations are prone to hydrolysis below pH 4, thus polydentate chelators are necessary for adequate stability 
during radiolabeling. Amongst the most stable complexes are observed for macrocyclic N3O3 donors due 
to the perfect fit of the metal in the macrocyclic cavity.52 1,4,7-triazacyclononane-1,4,7-triacetic acid 
(NOTA) analogues, 68Ga–NOTAMBP and 68Ga-NO2APBP were studied by Hermann and co-workers (Figure 
1.6). The complexation rates of these ligands were lower than those of NOTA, but almost quantitative 
labeling was achieved within 10 to 15 minutes. They also observed that during complexation of 68Ga–
NOTAMBP the amide group was hydrolytically unstable, thus rendering it unsuitable for radiopharmacy. 
68Ga-NO2APBP have similar pharmacokinetics to that of labeled DOTA-bis(phosphonate) conjugates, 
commonly used 99mTc-bis(phosphonate) radiopharmaceuticals and [18F]Na; however, it results in a 
significantly higher accumulation of 68GaNO2APBP on bone. The superior adsorption kinetics and 
convenient availability of 68Ga render 68GaNO2APBP as one of the best leading compounds for the 
development of bone-targeted PET probes.53 
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Figure 1.6:Macrocyclic N3O3 chelators (NOTAMBP and NO2APBP). 53 
1.1.2.2 Importance of the Chelating Molecule 
Incorporating a radionuclide in a TDDS requires a suitable chelator. Ideally the chelator should be able 
to perform a dual function of binding to the selected radionuclide and have high affinity for the 
overexpressed target in the tumor. The nature of the complex between the radionuclide and chelator should 
be kinetically inert and thermodynamically stable under physiological conditions, it should have rapid 
complexation kinetics and high specificity for the intended radionuclide, it should show high affinity for 
the intended target and finally the preparation should be simple and cost-effective. However, complexation 
of a radionuclide has a significant effect on the pharmacokinetics of radiopharmaceuticals.54 
The use of aminophosphonate chelators are justified by their high affinity for diseased bone and their 
capability to form stable complexes with an array of metals. Several natural occurring phosphonates have 
been isolated since the discovery of 2-aminoethanephosphonic acid in 1959 by Horiguchi and Kandatsu.55 
The interest devoted to understanding and exploiting organophosphorus compounds stems from similarities 
shared with their carboxylic counterpart (Figure 1.7).56 
 
Figure 1.7: (a) aminophosphonic acid (b) amino carboxylic acid 
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The chelating abilities of phosphonic acids are well known57 and with the addition of an amine moiety, 
improved binding abilities have been observed.58 Several reports can be found in the literature describing 
the binding interactions that exist between these compounds and alkaline earth-, transition-, and heavy 
metal ions.59 These properties have since been exploited in metal extraction60 and transport,61 catalysis,62,63 
as well as immobilization of catalysts.64,65 The ongoing studies regarding the coordination chemistry of 
organophosphorous compounds have enabled these compounds to act as promising moieties in a variety of 
fields. These include applications such as corrosion inhibitors66 and flame retardants67 or in agriculture as 
herbicides68 and pesticides.69,70 The biological aspects have been proven in their antimicrobial and 
antifungal properties.71 However, it was their intriguing medicinal applications that drew our attention. The 
characteristic N-C-P moiety has shown activity towards several receptors and enzymes as compatible 
substrates or as enzyme inhibitors,65,66 antibiotics74,75 and anticancer agents.76,77 The rationale for 
incorporating α–aminophosphonic acid on a dendrimer scaffold is twofold. They are suitable chelators for 
a range of radionuclides to prevent the nonspecific deposition of the radionuclide in tissues and secondly 
they exhibit inherent affinity for bone (HAp).  
Orvig et al. assessed the bone-targeting ability of four dipicolinic acid amine (dpa)-based ligands 
through solution depletion experiments to determine the influence of the R appendage on bone mineral 
targeting and binding using HAp as a model for the bone mineral (Figure 1.8). The introduction of the 
phosphonate moieties (c and d) provided clear evidence that phosphonates possess the ability to bind to 
HAp with moderate (c) and high (d) strength.78  
Bisphosphonates (BP) are considered to have the greatest bone-directing capability of any organic 
moiety to the extent that it becomes incorporated into newly mineralized tissue. This however can cause 
major side-effects due to its long-term retention within the bone matrix. Mono derivatized phosphonates 
are considered a viable option for facilitating the inherent bone-targeting ability, without itself impacting 
bone histology through long-term ligand accumulation.  
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Figure 1.8: Structures of four dipicolinic acid (dpa) ligands. 78 
A phosphorhydrazone dendrimer having azabisphosphonic acid (ABP) salt terminal groups, is known 
to interact with several biological aspects such as selectively promoting the multiplication of human natural 
killer (NK) cells.79 It also interacts with monocytes and induces their activation through an anti-
inflammatory pathway. They have been used to treat rheumatoid arthritis by inhibiting the development of 
inflammatory arthritis preventing cartilage destruction and bone erosion.80 Their activity can be associated 
with the symmetrical terminal phosphonic acid salts, the number of terminal functions as well as the type 
of internal structure.81 
  
Figure 1.9: Phosphorhydrazone dendrimer having azabisphosphonic acid (ABP) salt terminal groups. 82 
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Schiff-base ligands are another interesting set of ligands that has been used in biological applications. 
The condensation products of primary amines and carbonyl compounds yield an azomethine/imine and was 
first reported in 1864 by the German chemist Hugo Schiff (Figure 1.10).  
 
Figure 1.10: General structure of Schiff base (R = amino moiety, R’ = Carbonyl moiety). 
Otherwise known as Schiff bases, these compounds readily form complexes with most metals and 
numerous reports of their use in catalysis can be found.83,84 The diverse complexation and optical properties 
these ligands exhibit have seen them been used as metal extractants,85 potentiometric sensors86,  
photostabilizers87 and dyes for solar collectors.88 Several review articles discussing the biological 
importance of Schiff bases have regularly appeared in literature. These exemplify the use of Schiff bases in 
antibacterial,89 antifungal,90 antiviral,91 antimalarial,92 and antitumor93 applications. Some representative 
examples of biological applications of Schiff base complexes are briefly discussed here.  
Mendu et al. synthesized the Schiff base ligand 4-chloro-2–((4-oxo-4H-chromen-3yl) methylene 
amino) benzoic acid and its corresponding octahedral metal complexes of the type ML2 (Figure 1.11A). 
The complex showed intercalative binding to CT-DNA as determined by UV–Vis and fluorescence 
spectroscopic titrations as well as viscosity measurements. The nuclease activity of the above metal 
complexes shows that Cu (II) complex cleave DNA through redox chemistry. The biological activity was 
evaluated against four bacteria viz. E.coli, B.subtilis, pseudomonas and Edwardella and two fungi viz. 
penicillium and trichoderma. The complexes were found to be more active than the free ligand.94 Donnelly 
et al. evaluated a neutral, low molecular weight, lipophilic Ga(III) complex using a tetradentate N2O2 Schiff 
base ligand and the β-diketone curcumin as a bidentate auxilliary ligand to give a six-coordinate complex 
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(Figure 1.11B). They observed that the complex binds to amyloid-β plaques, which are accociated with 
Alzheimer's disease and concluded that the complex has potential as a imaging agent for PET.95  
 
Figure 1.11: (A) 4-chloro-2–((4-oxo-4H-chromen-3yl) methylene amino) benzoic acid and its corresponding Cu(II) 
complex94 (B) N2O2 Schiff base ligand, N,N-bis (2-ethoxysalicylidene)-1,2-diaminopropane and curcumin Ga(III) complex. 95  
 
1.1.2.3 Special focus on dendritic Biomolecules 
There are several types of nanoparticles that possess physicochemical properties that have drawn the 
attention of researchers. The main physicochemical features of nanocarriers are structure, composition, size, 
surface properties, porosity, charge, and aggregation behavior. Particle size influences properties such as 
vascular dynamics, diffusion, adhesion, uptake and clearance mechanisms which play a detrimental role in 
the efficacy of drug delivery. Similarly, the shape of the particle is known to influence properties such as 
internalization and selectivity of the particle. Surface characteristics such as charge and hydrophilic or 
hydrophobic nature influence circulation time and internalization. Figure 1.12 summarizes several 
nanoparticles used. These include viral nanoparticles, polymer-drug conjugates, metal nanoparticles and 
polymeric nanoparticles; however, for the purpose of this review, the focus will solely be on dendrimers as 
biomolecule segments of the nanocarrier vectors.  
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Figure 1.12: Common nanoparticles used for Targeted Drug Delivery System. 24 
Dendrimers currently receive active interest because of their unique chemical and physical properties as 
well as their wide range of potential applications. Dendrimers are highly branched polymers in the nano-
size region with three-dimensional, globular architecture which possess a high number of functional groups 
on the periphery. The controlled synthesis of dendrimers yields highly reproducible, monodisperse 
macromolecules that are unparalleled by any linear polymers. From a topological viewpoint dendrimer 
macromolecules have very specific architecture and contain three distinct domains: (a) The core at the 
center of the dendrimer, which consists either of a single atom or a molecule having at least two identical 
functional groups, (b) branches of molecules containing at least one focal point (branching point) and (c) a 
multivalent surface consisting of a high number of functional groups.96 The branching points are usually of 
such a nature that it allows for successive reactions to take place in a successive manner. This allows the 
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dendrimer molecule to form an ordered series of radially concentric layers if they are all connected to a 
core molecule. These “layers” are known as generations (G). 
 
Figure 1.13: Dendrimer Topography. 
The stepwise synthesis of dendrimers offers chemists the ideal opportunity to achieve macromolecules 
of a specific size, which in part influences the shape of the molecule.97 As the dendrimer generation 
increases, the functional groups at the periphery increases exponentially and the branches would normally 
adopt the least sterically hindered conformation. Thus, lower generation dendrimers exhibit linear 
conformations, whereas higher generation dendrimers adopt a spherical conformation. Further increase of 
dendrimer generation confines the branches and eventually reaches a point known as “de Gennes dense 
packing” limit. Dendrimers are typically the same size range of several biological structures and are 
considered to be biocompatible due to their ability to interact and cross cell membranes as well as their 
extended circulation time allowing for passive targeting via the EPR effect (Figure 1.14). 
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Figure 1.14: The effect that dendrimer generation has on physical properties and how it influences the biomedical potential. 98  
El-Sayed et al.99 investigated the influence of size, molecular weight, molecular geometry and the 
number of surface amine groups of PAMAM dendrimers (G0 – G4) to comprehend the relationship between 
these features and their permeability across Caco-2 cell monolayers. They determined that no single 
variable was responsible, but rather a combination of these parameters had an influence on their 
permeability and that G0 – G2 were best suited for oral drug delivery.  
Previous studies have shown the dendrimer conformation is influenced by several factors. The 
intramolecular interactions of the multivalent dendrimers are highly dependent on the properties of the bulk 
solution, i.e. polarity, ionic strength, and pH. Typical PAMAM and PPI dendrimers, possessing amine 
surface functionalities, adopt extended conformation at low pH due to electrostatic repulsion between 
protonated tertiary amines which forces the dendritic branches apart. At low pH, the hydrogen bonding 
between interior protonated tertiary amines and surface primary amines cause the branches to fold back and 
create a denser interior. Solvent polarity also affects dendrimer conformation. Apolar solvents favor 
intramolecular interactions; thus back-folding is favored. Polar solvents compete for these intramolecular 
interactions, thus allowing a more extended conformation (Figure 1.15).100 
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Figure 1.15: G6 PAMAM dendrimer configuration upon decreasing pH (left to right). 101 
The multivalent nature of dendrimers plays a crucial role in the pharmacodynamics and biodistribution 
profiles. Cationic dendrimers can interact non-specifically with negatively charged cell membranes, which 
can cause severe side effects. Thus, it is important to modify the cationic periphery and alter their 
cytotoxicity. Baker et al.102 modified G5 PAMAM dendrimers with folic acid before covalently coupling 
these acid–targeted dendrimers with methotrexate, radionuclides, and fluorescent dyes. The biodistribution, 
imaging potential, and antitumor efficacy of these drug delivery systems were evaluated and compared to 
free drug and non-targeted polymer controls. The targeted polymer-drug conjugate evidently displayed an 
improved therapeutic index based on a lower toxicity and an increase in drug effectiveness. 
Another valuable feature of dendrimers are the voids that exist within higher generation dendrimers. 
Depending on the size of the repeating subunit, these compartments are able to encapsulate smaller 
molecules. The multivalent surface of dendrimers aid in shielding the interior from the bulk solution, 
creating a microenvironment within the dendrimer. This important aspect renders dendrimers ideal for host-
guest interaction and encapsulation of guest molecules.96-103 Vogtle et al. demonstrated the host-guest 
capability of azobenzene modified PPI dendrimers (Figure 1.16). The photochemical and photophysical 
properties of solutions containing dendrimers and the potential host eosin Y (2’,4’,5’,7’-
tetrabromofluorescein dianion) were monitored by fluorescence spectroscopy. The strong fluorescence 
band of eosin Y decreases in the presence of the dendrimers by a static mechanism which implies the 
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quenching occurs due to association between the eosin and the dendrimer. The quenching is most likely 
due to an electron-transfer reaction between the singlet excited state of eosin and the tertiary amine units 
present along the branches of the dendrimers. 29  
 
Figure 1.16: Photo-switchable azobenzene modified PPI dendrimers hosting eosin. 29 
1.1.2.4 Influence of the Linker Molecule 
The linker molecule connects the drug and biomolecule and its purpose is to alter the 
pharmacodynamics for improved selectivity and efficacy of radiopharmaceuticals. The linker is responsible 
for the release profile and excretion kinetics of the drug. Biodegradable linkers offer the opportunity of 
enzymatic degradation which alter the rate at which the drug is released (high amounts of drug immediately 
or small amounts over time)104 and rate of excretion of low molecular weight degradation products (reduce 
the non-tumor uptake and retention while maintaining a high tumor uptake). Several types of linkers such 
as cationic, anionic, neutral and metabolically cleavable have been reported before (Figure 1.17). 
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Figure 1.17: Cationic, Anionic, Neutral and Cleavable linker molecules. 52 
Tumors generally exhibit an acidic microenvironment (pH 5.8 – 7.3), thus several pH sensitive linkers 
have been utilized to achieve selective drug delivery. Amide and hydrozone linkages were used to attach 
doxorubicin to dendrons and the latter was cleaved at low pH, facilitating drug release.105 Alternative pH 
sensitive linkages, Cis-aconityl, were compared to stable succinic linkages and the former exhibited 
improved drug action.106 Kaminskas et al. evaluated a different pH sensitive linker, 4-hydrazinosulfonyl 
benzoic acid linker (HSBA), to facilitate release of doxorubicin in the acidic microenvironment of a solid 
tumour.107 Bone specific enzymes such as matrix metalloproteinases (MMP) are expressed by osteoclasts 
and osteoblasts. MMPs degrade collagen, basement membranes and cleave peptide bonds. These enzymes 
have previously been explored as targets for selective drug release.108 These linkers are inhibited by 
tetracycline and derivatives such as doxycycline.109  
The prospect of using dendrimers as radiopharmaceuticals have received little attention in literature, 
especially reports of dendritic radiopharmaceuticals that combine all the aspects of a TDDS. Although as 
early as 1994, Gansow et al. reported the use of PAMAM dendrimers coupled with DOTA derivatives as 
multinuclear scaffolds for 90Y, 111In, 212Bi and Gd (III) metals. They were able to incorporate monoclonal 
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antibodies (mAb) for tumor-targeted delivery of these nuclides.110 Another preclinical study conducted by 
Notni et al. evaluated trimeric TRAP-bisphosphonate-conjugates of gallium-68 as potential PET agents. 
The structure of these conjugates resembles that of dendrimers where the complex forms within the 
macrocyclic core and is stabilized by the interior phosphonates to form an ‘in-cage’ complex, leaving the 
bisphosphonate on the periphery to interact with bone.  
 
Figure 1.18: Trimeric TRAP-bisphosphonate conjugates TRAP(MDP)3 and TRAP(PDP)3. 
More recently, Laznickova et al. described coupling a DOTA analogue via a pyridine-N-oxide link to 
G1 and G4 PAMAM dendrimers. These dendritic conjugates were readily labeled with 177Lu forming 
complexes which are stable for at least 24 h both in physiological solution and in the presence of 100-fold 
molar excess of EDTA or DTPA. They concluded that dendrimer radiometal chelate conjugates could serve 
as a construct to add antibodies in order to obtain markedly high specific activity and minimal loss of their 
immunoreactivity.111 
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1.1.3 Project rational and Objectives 
The aim of this study was to design a targeted drug delivery system (TDDS) that can potentially act as 
an anti-cancer agent. The size, shape and surface characteristics influence the pharmacodynamics and 
pharmacokinetic properties of the TDDS. The unique properties of dendrimers (size, shape and 
multifunctional periphery) advocate its use as a multinuclear scaffold ideal for targeted cancer diagnostic 
and radiotherapy. With this in mind, generation 1 PAMAM dendrimers based on cyclam (N4) and TACN 
(N3) macrocycles were prepared and characterized for their use as dendritic scaffolds. Their multivalent 
periphery allows for the incorporation of several chelator molecules able to interact with both radionuclides 
and target receptors. Thus, these scaffolds were subsequently modified with phosphonic acid as well as 
salicylaldehyde to yield the respective dendritic ligands. Once these dendritic ligands are obtained they will 
undergo complexation reactions with gallium and copper to form the “cold” metallodendrimers. Finally, 
the DNA binding capabilities of all the suitable compounds would be evaluated via UV-Vis spectroscopic 
titrations.  
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2 Synthesis and Characterization of Cyclic cored PAMAM, PPI and BA 
Dendritic Ligands  
2.1 Introduction 
In this chapter an introduction pertaining to the synthesis of dendrimers is discussed, highlighting 
the advantages and disadvantages of the divergent and convergent synthetic approaches. Thereafter, a 
brief summary of heteronuclear macrocycles and the properties it potentially adds to dendrimers when 
incorporated into the dendritic framework provide the rationale for investigating macrocyclic-cored 
dendrimers. The subsequent experimental section conveys our results for the synthesis of generation 1 
cyclam-cored poly(amidoamine) (PAMAM) dendrimers via a two-step process. The first, a Micheal 
addition, was attained following a microwave-assisted method before the subsequent amidation step 
yielded the full generation dendrimer. The attempts made to obtain generation 2 cyclam-cored PAMAM 
and generation 1 TACN-cored PAMAM dendrimers following the aforementioned two-step method, 
are also discussed. The last section deals with attempts made to achieve higher generation dendrimers 
via an alternative nitrile reduction method, where the attempted synthesis of generation 1 cyclam-cored 
polypropylamine (PPI) and benzyl amine (BA) dendrimers is discussed (Figure 2.1). 
 
Figure 2.1: General summary of all dendritic target compounds. 
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2.1.1 Conventional Approaches to Dendrimer Synthesis 
Dendrimers are defined as highly branched polymers or macromolecules that are three 
dimensional, globular, and monodisperse in nature. The first successful attempt to design and create 
dendrimer molecules was reported by Vögtle and co-workers1 in 1978 who used the term “cascade 
molecules” to describe their compounds. After the first report, several years passed before Tomalia et 
al.2 reported on independent research done by their group at the DOW Chemical Company. In 1984, 
they coined the term “dendrimer” to describe in detail their divergent synthesis of poly (amidoamine) 
(PAMAM) dendrimers. Soon thereafter Newkome et al.3 described the synthesis of arborols. The first 
report on an alternative synthetic approach viz. convergent dendrimer synthesis was published by 
Frechet4 in 1990, in which the synthesis of poly-benzylether dendrimers with low polydispersity was 
reported. There are several reports in literature pertaining to methods for dendrimer synthesis such as: 
(i) hypercores and branched monomers, (ii) double exponential, (iii) lego chemistry and (iv) click 
chemistry.5 Generally all the strategies available for dendrimer synthesis can be grouped into two 
categories; namely divergent- and convergent synthesis. 
 
Figure 2.2: Graphical representation of divergent and convergent synthesis. 
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2.1.1.1 Divergent Synthesis 
The divergent approach, which was independently introduced by Vögtle et al.1 and Tomalia et al.2, 
follows a stepwise construction of dendrimers starting from a multifunctional core molecule and 
building outwards towards the periphery. This can be achieved by the coupling of branching monomers 
or the deprotection/ transformation of the branching monomer end group, to create another reactive 
group capable of coupling a subsequent branching monomer. The divergent synthetic approach offers 
the ability to achieve high generation dendrimers with surface functionalities that can easily be 
transformed to alter the dendrimers properties. The divergent approach is the ideal method for 
commercial scale dendrimer synthesis.5 There are however some drawbacks worth noting. The rapid 
increase in the number of end groups combined with the increase in molecular weight results in slower 
reaction kinetics, which often hampers the synthesis of higher generation dendrimers. Also, as the 
dendrimer generation increases, it becomes increasingly difficult to separate the desired products from 
any by-products due to their molecular similarities.6 PAMAM dendrimers have been used to identify 
possible imperfections encountered during dendrimer synthesis namely (a) ester hydrolysis leading to 
a dead branch, (b) retro-Michael addition leading to a missing branch (c) intramolecular cyclization, 
and (d) intermolecular cyclization.7  
 
Figure 2.3: Possible side reactions during PAMAM synthesis: (a) ester hydrolysis leading to a dead branch (b) retro-
Micheal addition leading to a missing branch (c) intramolecular cyclization, (d) intermolecular cyclization. 
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2.1.1.2 Convergent Synthesis 
Segment coupling strategies were used for peptide synthesis to overcome the low reactivity of the 
stepwise divergent synthesis of large oligopeptides.8 Fréchet et al.4 applied the convergent approach to 
obtain dendrimers, where the dendrimer is synthesized from the peripheral groups inwards towards the 
core. Essentially two branching monomers are coupled to create a dendritic segment called a dendron. 
The subsequent coupling of these dendrons lead to a higher generation dendrimer. Once the desired 
generation is achieved, the dendrons are bound to a suitable core molecule to create the dendrimer. 
During the dendron propagation process, the number of reactive sites are kept at a minimum, thus the 
reaction rates generally remains constant and higher yields are obtained relative to the divergent 
approach. The convergent approach is also superior when comparing the product purity obtainable, due 
to the molecular differences between the dendrons and the dendrimers which facilitates easy separation 
and thus high purity dendrimers.6 The convergent approach does come with some limitations. In order 
to obtain higher generations, the amount of coupling reactions during dendron synthesis increase 
exponentially, thus the consecutive dendrons become more bulky. These bulky dendrons can possibly 
restrict the subsequent “core coupling reaction”. This may lead to situations where entire branches are 
missing (Figure 2.4).7  
 
Figure 2.4: Convergent approach; showing possible restriction of “core coupling reaction” due to bulky dendrons. 
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2.1.2 Macrocycles as dendrimer cores 
The step-wise synthesis of dendrimers provide chemists with the control to carefully design 
dendritic macromolecules. Thus, keeping the intended function in mind, dendrimers can be specifically 
tailored by incorporating chemical moieties at predetermined sites that contribute specific properties 
derived from the constituent moieties. One such example is the incorporation of macrocycles into the 
dendritic structure. These dendrimer-macrocycle conjugates can be categorized into a range of 
architectures according to the position of the macrocycle. These include dendrimers synthesized with 
macrocycles at its periphery, a macrocycle at its core, macrocycles at both its periphery and core, 
macrocycles attached to the interlayer of the dendrimer9 as well as macrocycles attached to each layer 
of the dendrimer.10  
A heteronuclear macrocycle is defined as a cyclic macromolecule containing three or more donor 
atoms and a ring size of at least nine atoms.11 Macrocycles containing oxygen donor groups, are known 
as crown ethers, whereas, those containing nitrogen donor groups, are known as azamacrocycles. The 
interest shown towards macrocycles was initiated by Pederson, who in the 1960’s synthesized a library 
of polyethers and demonstrated their enhanced complexing ability with a range of alkali and alkali earth 
metals.12 Binding constants generally increase as the number of donor atoms per ligand molecule 
increases. For example, bidentate (two donor atoms per ligand molecule) ligands show improved 
coordination stability relative to monodentate ligands, as a result of the chelate effect. The 
rationalization behind the so called chelate effect is twofold. Primarily the substitution of two 
monodentate ligands by a single bidentate ligand, increase the amount of species in the system. The 
system becomes more disordered, thus from a thermodynamic point of view, an increase in entropy 
occurs (Figure 2.5a). Additionally, as soon as the first donor atom of a bidentate ligand coordinate to a 
metal ion, the second donor atom is restricted to move in close proximity of the metal. The probability 
of the second donor atom binding to the metal is much greater compared to a monodentate ligand 
randomly dispersed in solution (Figure 2.5b).  
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Figure 2.5: The Chelate effect. 
In the case of a macrocyclic ligand, all the donor atoms are connected forming a ring structure, 
which enhances the coordination stability further. This is known as the macrocyclic effect which is a 
combination of several properties such as the electronics of the donor atoms13, the molecular geometry, 
bond length between metal and donor atom, as well as the number and flexibility of the connections 
between the donor atoms. The conformational attributes of macrocycles ensure their donor atoms are 
pre-organized. Typically, a macrocycle already resides in the preferred conformation it would adopt 
upon complexation, thus limited conformational changes are required. Furthermore, the close proximity 
of the donor atoms in a macrocycle leads to electrostatic repulsion; however, upon complexation the 
repulsion is lost.  
When combining both types of macromolecules (dendrimers and macrocycles), an expected 
increase in the level of pre-organization is observed which might induce synergistic effects affording 
interesting properties, different from those produced by the separated entities.14 The first dendritic 
compound containing macrocycles in its architecture was reported by Nagasaki and co-workers15 and 
concerned a dendrimer bearing azacrown ether macrocycles as constituents of each branch. Dendrimers 
with macrocycles at its core are known to adopt a unique shape based on the nature of the macrocycle. 
The chosen macrocycle therefore plays a cooperative role in the dendritic effect observed. The 
‘dendritic effect’ is a collective term widely used to describe the unusual physico-chemical properties, 
 
 
A 
B 
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patterns or trends observed for dendrimers as their generations grow. These properties may either be 
maximised (i.e. a positive effect) or minimized (i.e. negative effect) within a dendrimer series.16  
2.2 Results and Discussion 
The divergent synthesis of PAMAM type dendrimers entails a two-step process. The first step is 
the Michael addition reaction between methyl acrylate and a suitable amine, followed by an amidation 
step with ethylenediamine (EDA). The conventional method describes carrying out the Michael 
addition reaction at room temperature for 3 days followed by the amidation reaction for a further 5 days 
in the dark.17 In a bid to develop a method that is not as time consuming as the conventional method, 
we report herein a method exploiting the advantages of microwave radiation. The advantages of 
microwave assisted reactions (thermally driven reaction) stems from their mode of energy transfer. 
Conventional methods rely on conductive heating which is dependent on the thermal conductivity of 
various materials. Microwave assisted methods induce a rapidly changing electric field directly to the 
reactants. Any polar or ionic species attempts to orientate itself with the changing field which results in 
a transfer of energy via dipole rotation or ionic conduction. This method of heating in microwave 
assisted reactions is more efficient and circumvents the thermal conductivity of materials. Also, the 
electromagnetic energy of a microwave (300 – 300 000 MHz) affect the molecular rotation of molecules 
and not the molecular structure. This is due to the low energy of microwave photons (0.037 kcal/mole) 
relative to the energy required to cleave molecular bonds (80 – 120 kcal/mol).  
Following a microwave assisted method, the first step (Micheal addition reaction) could be 
completed in less than an hour compared to the conventional 3 days. Unfortunately, all attempts to 
complete the subsequent amidation step via a microwave-assisted method did not yield the desired full 
generation dendrimers with sufficient purity, hence the conventional method was employed for this 
step. Furthermore, the cyclam and TACN cored PAMAM dendrimers were characterized via Fourier-
transform infrared spectroscopy (FT-IR), proton and carbon nuclear magnetic resonance (1H NMR and 
13C NMR) and where possible with mass spectrometry (MS) and elemental analysis (EA).  
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2.2.1 Synthesis of Cyclam and TACN cored PAMAM dendrimers  
The synthesis of G0.5 cyclam-cored PAMAM dendrimer (D1) was attempted via the conventional as 
well as the microwave assisted method. The conventional method, albeit with a low yield of 40 %, was 
successful. However, employing a microwave assisted method the reaction was completed in 
significantly less time and higher yields (99 % yield). Reaction Scheme 2.1 depicts the microwave 
assisted method followed.  
 
Reaction Scheme 2.1: Microwave-assisted synthesis of D1. 
The microwave assisted method previously developed by our group18 was modified where instead 
of 15 minutes the reaction was stirred for 25 minutes with only 50 W of radiation compared to 300 W. 
Thus, the Michael addition was done with 2.5 mole equivalent methyl acrylate per reactive site in the 
microwave reactor at a controlled temperature of 38 °C with 50 W radiation for 25 minutes. Removal 
of the solvent and excess methyl acrylate under reduced pressure produced a light yellow/transparent 
oil. The oil was purified by adding cold hexane and vigorously scratching the oil with a spatula, while 
submerged in an ice-acetone bath. At this cold temperature, the oil became a white solid after a couple 
of minutes of trituration. D1 was isolated via filtration as a white, air stable solid in almost quantitative 
yield. 
The FT-IR spectrum (Figure 2.10: D1) displayed a band at 1731 cm-1 corresponding to the carbonyl 
stretch νC=O. No trace of the νN-H stretch present in the cyclam starting reagent was observed. In the 1H 
NMR spectrum, the methoxy protons (Reaction Scheme 2.1: g) was observed as a singlet at 3.64 ppm 
integrating for a total of 12 protons. The 13C NMR spectrum displayed the carbonyl carbon (Reaction 
Scheme 2.1: f) at 173.33 ppm. These results correspond with the expected and reported data for D1. 
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The subsequent amidation of D1 with EDA was attempted via a conventional as well as a 
microwave-assisted method.19 The preliminary reactions via the microwave assisted method indicated 
the presence of several products in the crude material. The FT-IR spectrum showed the carbonyl stretch 
shift to lower wave numbers as expected, which indicated that all the ester functionalities had reacted. 
However, in the proton NMR spectrum not only the expected peaks for the product, but various other 
peaks were observed which are possibly due to inter/ intramolecular crosslinking via the amine 
functionalities of the EDA and ester functionalities of the dendrimer (Figure 2.6). Several attempts were 
made to purify the mixture, but attempts on separating the crude products using extraction techniques 
and based on solvent polarity was unsuccessful. Thus, for the synthesis of G1 cyclam-cored PAMAM 
dendrimer (D2) only the conventional method as described by a literature procedure17 was pursued 
further. The conventional method followed is depicted in Reaction Scheme 2.2.   
 
Reaction Scheme 2.2: Conventional synthesis of D2. 
The procedure involves adding a large excess EDA as a dilute solution in dry ethanol to D1 and 
stirring the sealed reaction mixture at room temperature in the dark for 5 days. Performing the reaction 
in the dark using a dilute reaction mixture was required to prohibit any inter/ intramolecular crosslinking 
(Figure 2.6). Removal of the solvent and excess EDA under reduced pressure produced a viscous yellow 
oil. Purification entailed dissolving the oil in a minimum amount of methanol before submerging the 
solution in an ice bath. Following this, diethyl ether was slowly added to the vigorously stirring solution. 
After approximately an hour, a sticky white precipitate was isolated by siphoning of the mother liquor. 
This process was repeated 3 times before drying the precipitate under reduced pressure to isolate D2 as 
an off-white, hygroscopic solid in almost quantitative yield.  
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Figure 2.6: Possible inter/ intramolecular crosslinking during D2 synthesis. 
The FT-IR spectrum (Figure 2.10: D2) displayed a shift of the νC=O stretch from 1731 cm-1 to 1628 
cm-1, which corresponds to the transformation of the ester moiety to an amide. Further characterization 
by NMR spectroscopy confirmed that the amidation reaction was successful. In the 1H NMR spectrum 
(Figure 2.7: bottom spectrum) the resonances corresponding to the aliphatic protons (Reaction Scheme 
2.2: g and h) are observed as a doublet of doublets and triplet at 3.28 ppm and 2.81 ppm, respectively. 
The doublet of doublet stems from the 3JH-NH and 3JH-CH coupling. These resonances are observed at 
42.17 ppm (g) and 41.66 ppm (h) in the 13C NMR spectrum. The resonance of the carbonyl carbon can 
be seen at 172.87 ppm. The chemical shift for the protons and carbons corresponding to d and e in 
Reaction Scheme 2.2 show no significant shift. These results correspond with the expected and reported 
data for D2.  
Additional characterization via elemental analysis indicated that the sample consisted of N: 28.45 
%; C: 48.85 %; H: 10.89 %. It should be noted that the sample was hygroscopic and the results suggest 
that the sample has some ethylenediamine, methanol and water trapped within the dendrimer 
framework. The calculated values of D2 with four molecules of ethylenediamine and two molecules 
each of methanol and water (N: 28.09 %; C: 48.17 %; H: 10.91 %) correspond well with the 
experimental values. Furthermore, it was possible to identify the molecular ion as well as several 
fractions from the electrospray ionization mass spectrometry (ESI-MS) results. The spectra obtained 
indicated the singly charged molecular ion [M + H]+ at 657 m/z (Figure 2.8). 
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Figure 2.7: Top spectra: 1H NMR of D1; bottom spectra: 1H NMR of D2. 
 
Figure 2.8: ESI-MS spectra of D2. 
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A plausible fragmentation pathway is depicted in Figure 2.9. The difference from the molecular 
peak to the peak at 597 m/z corresponds to the ionization of the amide carbon-nitrogen bond (loss of I). 
Further ionization of the carbon-nitrogen bond linking the cyclam and the branches was observed at 
543 m/z (loss of II). Subsequently, each arm undergoes the same fragmentation as evidenced by the 
peaks at 483 and 429 m/z which corresponds to the loss of two fragments each of I and II.  
 
Figure 2.9: Possible fragmentation pattern of D2. 
Based on the results above, the synthesis of generation 1 cyclam-cored PAMAM dendrimer was 
successful. The next step was to attempt the synthesis of generation 2 analogues. Thus, the amine 
terminated dendrimer D2 was subsequently subjected to a conventional Michael addition reaction 
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(Reaction Scheme 2.3) to yield D3 as a viscous yellow oil in moderate yields. The product was 
characterized by FT-IR and 1H - and 13C NMR spectroscopy. 
 
Reaction Scheme 2.3: Conventional synthesis of D3. 
The FT-IR spectrum (Figure 2.10: D3) shows two νC=O bands at 1728 cm-1 and 1644 cm-1 
corresponding to the ester and amide moieties, respectively. The absorption observed at 3308 cm-1 is 
from the secondary amide νN-H stretch. The 1H NMR spectrum display a triplet resonating at 7.19 ppm 
corresponding to the amide N-H. The methoxy protons (Reaction Scheme 2.3: l) resonate as a singlet 
at 3.62 ppm integrating for a total of 24 protons. The protons corresponding to d, e, g and h in Reaction 
Scheme 2.3 are observed at 2.29, 2.49, 2.38 and 2.72 ppm, respectively. In the 13C NMR spectra two 
carbonyl carbon resonances are seen at 173.00 ppm (Reaction Scheme 2.3: k) and 172.34 ppm (Reaction 
Scheme 2.3: f) corresponding to the ester and amide moiety. The methoxy carbons (Reaction Scheme 
2.3: l) are seen at 49.34 ppm. The characterization data obtained for D3 corresponded well with the 
expected data, thus no further characterization was done as D3 is just an intermediate towards 
generation 2 cyclam-cored PAMAM dendrimers.  
In an attempt to synthesize G2 cyclam-cored PAMAM dendrimer (D4), the ester functionalized 
dendrimer D3 was subjected to a similar amidation reaction (Reaction Scheme 2.4) followed for the 
synthesis of D2. The method differs from D2 only in the amount of time it was allowed to stir. After 5 
days, a small sample of the reaction mixture was worked up and analyzed via FT-IR which indicated 
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the presence of unreacted ester moieties still present. This was done several times and after 20 days it 
was decided to stop the reaction. During the removal of the solvent and EDA, a fine white precipitate 
was observed in the concentrated solution, which was subsequently isolated via filtration before 
removing the rest of the solvent and excess EDA to produce a dark yellow viscous oil. The oil was 
subjected to the same purification procedure described for D2. 
 
Reaction Scheme 2.4: Attempted Synthesis of D4. 
Analysis of the oil via FT-IR (Figure 2.10: D4) displayed no more νC=O stretch originating from 
the ester carbonyl of D3. The νC=O stretch had shifted from 1728 cm-1 to 1632 cm-1 indicating no ester 
moiety remained after the reaction. The absorption band at 3259 cm-1 represents the amide νN-H stretch. 
The 1H NMR spectra of D4, obtained in D2O, show several overlapping peaks in the range of 2.3 – 3.5 
ppm, with two distinct triplets at 3.1 ppm and 2.8 ppm which could not accurately be integrated due to 
the lack of peak resolution. These resonances are most likely caused by a combination of the protons 
represented by g and l for the peaks at 3.2 ppm and a combination of h and m for the peaks at 2.8 ppm 
in Reaction Scheme 2.4. There also seems to be some evidence of methoxy protons resonating around 
3.35 ppm. This contradicts the FT-IR results as this would mean that there are still unreacted ester 
moieties from D3. The 13C NMR display more than expected carbonyl carbon resonances in the region 
of 173 ppm, which supports the evidence that there still remain unreacted ester functionalities. Thus, 
the crude oil seems to be a combination of several products which could not be separated even after 
several different attempts to purify and optimize the reaction conditions. 
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Next, an attempt was made to identify the white precipitate isolated during work-up to clarify what 
occurred during the reaction. Lopp and co-workers were able to separate a range of side products 
encountered during the synthesis of G0 – G5 PAMAM dendrimers. They isolated and identified 
intramolecular cyclization products (Figure 2.3 pathway d) from as early as G1 dendrimer.20 In an 
earlier paper they also identified that another source of structural defects occurring with PAMAM is the 
retro-Michael reaction (Figure 2.3 pathway c). The equilibrium reaction in methanol was evident even 
at low temperatures (4 – 50 °C). The equilibrium is dependent on temperature, solvent and time.21 
The FT-IR analysis of the fine white precipitate indicated a sharp νN-H stretch at 3278 cm-1 as well 
as a νC=O stretch at 1670 cm-1. These peaks are expected to appear for the product D4. However, further 
characterization via NMR proved that the white precipitate did not contain any of the peaks 
corresponding to the cyclam core, nor the PAMAM branches. The 1H NMR spectra (Figure 2.11: Top) 
of the precipitate showed two triplets and a singlet at 3.31 ppm, 3.07 ppm and 3.00 ppm, respectively. 
In the 13C NMR spectra (Figure 2.11: Bottom) two resonances appear in the carbonyl region of 160-
165 ppm and three peaks in the region of 40 ppm. 
 
Figure 2.10: FT-IR spectra of D1 - D4.
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Figure 2.11: Top: 1H NMR of isolated precipitate; Bottom: 13C NMR of isolated precipitate. 
The reaction was done in methanol for extended time at room temperature, which varied between 
20 – 35 °C, thus according to the findings of Lopp and co-workers it is likely that intramolecular 
cyclization and retro-Michael addition could occur. The FT-IR and NMR data of the white precipitate 
suggest evidence of intra-ligand cyclization and corresponds to the proposed structure in Figure 2.12. 
This species could have formed through a combination of intra-ligand cyclization, hydrolysis and/or 
retro-Micheal addition; however, neither retro-Michael reaction nor hydrolysis seems plausible to 
obtain the proposed structure. Further characterization of the precipitate was done by means of 
microanalysis and ESI MS. In the ESI MS spectra the molecular ion sodium adduct [M + Na]+ appeared 
at 208 m/z and the molecular ion methanol adduct appeared at 218 m/z. However, the elemental analysis 
results indicated a large difference between the experimental and calculated values based on the 
proposed structure (Experimental: N: 39.045 %; C: 39.278 %; H: 8.632 %, Calculated: N: 22.69 %; C: 
51.88 %; H: 8.16 %). The difference could not be accounted for even with the addition of several 
combinations of solvent molecules/reagents used during the synthesis. Based on these results the 
synthesis of D4 was unsuccessful due to the formation of several side products. Therefore, obtaining 
Stellenbosch University  https://scholar.sun.ac.za
Synthesis and Characterization of Cyclic cored PAMAM, PPI and BA Dendritic Ligands 
52 
 
higher generation PAMAM dendrimers is not feasible following this method due to the irreproducibility 
of the amidation reaction yielding impure crude products that requires tedious purification procedures 
if at all possible.  
 
Figure 2.12: Amidation reaction of D4 showing possible side products formed. 
 
In order to obtain higher generation cyclic cored dendrimers other alternatives were pursued. By 
changing the core molecule, the steric interaction experienced between the dendrimer branches could 
be altered (Figure 2.4). Thus, 1,4,7-triazacyclononane (TACN) was selected as a viable cyclic core as 
it only allows 3 branches to grow from its core thereby reducing the steric interaction that may cause 
hindrance further along the synthesis. Hence, Trimethyl 3,3',3''-(1,4,7-triazonane-1,4,7-
triyl)tripropanoate (D5) was synthesized according to the microwave-assisted Michael addition reaction 
discussed above (Reaction Scheme 2.1) and isolated as a white solid (Reaction Scheme 2.5).  
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Reaction Scheme 2.5: Microwave-assisted synthesis of D5. 
The FT-IR spectrum shows a sharp ester νC=O peak at 1731 cm-1. In the 1H NMR spectrum the 
methoxy protons are expected to resonate in the region of 3.6 - 3.8 ppm and a singlet at 3.65 ppm 
integrating for a total of 9 protons is assigned to these protons. The 13C NMR spectrum displays the 
signal for the carbonyl carbon resonating at 173.4 ppm as expected. No further characterization was 
deemed necessary to continue to synthesize the G1 TACN-cored PAMAM dendrimer.  
The tri-ester functionalized TACN dendrimer (D5) was subjected to the same amidation procedure 
previously discussed (Reaction Scheme 2.2) in an attempt to obtain D6 (Reaction Scheme 2.6). 
 
Reaction Scheme 2.6: Attempted synthesis of D6. 
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The FT-IR spectrum displays a shift in the νC=O stretch from 1731 cm-1 to 1642 cm-1 corresponding 
to amide carbonyl. The νN-H band is also observed at 3269 cm-1. In the case of D6, the 1H NMR spectrum 
showed no trace of the signal or the methoxy protons of D5. The spectrum displayed several overlapping 
peaks in the range of 2.4 – 3.4 ppm and as with D4, these signals could possibly be due to species in 
which dendrimer units are cross-linked.  
In summary, obtaining higher generation cyclic cored PAMAM dendrimers via the method 
followed above proved to be cumbersome. The Michael addition proceeded with no trouble and the 
reaction time was reduced from 3 days to 30 minutes with the microwave assisted method. The FT-IR 
results (summarized in Table 2.1) indicate a strong νC=O stretch in the region 1720 -1730 cm-1 for the 
half generation dendrimers (D1, D3, D5) which was assigned to the carbonyl moiety of the ester 
functional group. Further characterization via NMR (summarized in Table 2.2 and Table 2.3) supported 
the success of the Michael addition reactions as evident from the methoxy protons and carbonyl carbons 
in their respective 1H and 13C NMR. The problem with this synthetic procedure occurred during the 
amidation step. The FT-IR results of the full generation dendrimers (D2, D4, D6) showed the 
disappearance of the ester νC=O stretch accompanied by the appearance of an amide νC=O stretch at lower 
wavenumbers (1640 cm-1) and a strong νN-H stretch at 3250 – 3300 cm-1. These results seem promising, 
but upon further characterization via NMR some impurities/defects were observed, especially with the 
higher generation dendrimer.  
Table 2.1: FT-IR data pertaining to dendrimer synthesis. 
Compound 
 FT-IR (cm-1)d 
 ν(C=O)e  ν(C=O)f  ν(N-H)stretch 
D1a  1731  -  - 
D2b  -  1628  3294 
D3c  1728  1644  3308
 
D4b  -  1632  3259 
D5a  1731  -  - 
D6b  -  1642  3269 
Reaction conditions: aMw: 25 min, 38 °C, 50 W; bMeOH, r.t. 5 days, dark; cMeOH, r.t. 5 days; dRecorded as neat 
spectra on a ZnSe crystal, employing an ATR accessory; eEster; fAmide. 
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Table 2.2: 1H NMR spectral data of dendrimers D1–D6. 
Compound  -C(O)OCH3  -C(O)-NH-CH2-CH2-NH2  -C(O)-NH-CH2-CH2-NH2 
D1a  
3.64 (s, 
12H) 
 -  - 
D2a  -  
3.28 (dd, J = 11.7, 5.8 Hz, 
8H) 
 2.81 (t, J = 6.0 Hz, 8H) 
D3a  
3.62 (s, 
24H) 
 3.23 (dd, 8H)  2.68 (t, 8H) 
D4b  3.35 (s)  3.27 (t)  2.81 (t) 
D5a  3.65 (s, 9H)  -  - 
D6b  -  3.28 (m)  2.79 (m) 
aSpectra run in CDCl3 at 25 °C; 
bSpectra run in D2O at 25 °C. Chemical shifts reported as δ ppm values, referenced relative to residual 
solvent peak.   
 
Table 2.3: 13C NMR spectral data of dendrimers D1–D6. 
Compound 
13C NMR (ppm) 
-C(O)OCH3  -C(O)OCH3  C(O)NH-  CH2-CH2-NH2  CH2-CH2-NH2 
D1a 50.61  173.33  -  -  - 
D2a -  -  177.75  44.17  42.36 
D3a 49.34  173.00  172.34  37.21  - 
D4b -  -  -  -  - 
D5a 55.65  173.41  -  -  - 
D6b -  173.32  172.74  -  - 
aSpectra run in CDCl3 at 25 °C; 
bSpectra run in D2O at 25 °C. Chemical shifts reported as δ ppm values, referenced relative to residual 
solvent peak.   
 
2.2.2 Synthesis of Cyclic cored PPI and BA dendrimers 
Not cowering from the problem at hand, another alternative towards obtaining higher generation 
cyclic cored dendrimers was attempted. In this case, the use of different branching units were chosen to 
circumvent the issues occurring during the amidation step of PAMAM branches. Acrylonitrile and 4-
bromomethyl benzonitrile were identified as viable Michael acceptors to obtain half generation 
dendrimers. These dendrimers possessed a nitrile moiety on their peripheries that could subsequently 
be reduced to yield polypropylenimine (PPI) and benzyl amine (BA) dendrimers. The following section 
deals with the synthesis of cyclam-cored PPI and BA dendrimers and their characterization via Fourier-
transform infrared spectroscopy (FT-IR), proton and carbon nuclear magnetic resonance spectroscopy 
(1H NMR and 13C NMR) and where possible with mass spectrometry (MS) and elemental analysis (EA). 
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The synthesis of 3,3',3'',3'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrapropanenitrile 
(D7) was previously reported by Wainright.22 The first step is the Michael addition reaction between 
cyclam and acrylonitrile, which was done via two methods. The first being a reaction done at room 
temperature for 24 hours and the second a microwave-assisted reaction as shown above (Reaction 
Scheme 2.1). In both methods, the product was isolated as a white crystalline precipitate in moderate to 
high yields (≈ 80 % yield). The numbering used for the following discussion is depicted in Reaction 
Scheme 2.7. 
 
Reaction Scheme 2.7: Microwave-assisted synthesis of D7. 
The FT-IR spectrum (Figure 2.13: D7) displayed no νN-H stretch originating from cyclam and a 
sharp νCN at 2243 cm-1. The 1H NMR spectra showed two triplets resonating at 2.57 and 2.75 ppm 
corresponding to the aliphatic protons e and d, respectively. The corresponding signals were also 
observed in the 13C NMR spectrum at 51.40 ppm (d) and 16.51 ppm (e). The resonance corresponding 
to the nitrile carbon (f) was observed at 119.36 ppm. These observations confirm that the microwave-
assisted Michael addition was successful.  
The subsequent reduction step has previously been attempted by our group. The use of LiAlH4 and 
NaBH4 as reducing agents yield a mixture of products. The use of Raney-Nickel and KBH4 also showed 
only partial reduction.23 In order to acquire 3,3',3'',3'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-
tetrayl)tetrakis(propan-1-amine) (D8), a modified procedure previously reported by Wainright24,25 was 
followed (Reaction Scheme 2.8).  
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Reaction Scheme 2.8: Attempted synthesis of D8. 
D7 was refluxed in toluene with solid sodium metal suspended in the light-yellow solution. After 
20 hours, dry ethanol was slowly added which resulted in the formation of H2 gas bubbling through the 
solution. The ethanol was added in a manner to sustain more or less a constant source of H2. After 
approximately 3 hours all the sodium had dissolved and no more H2 was released. The reaction mixture 
was refluxed an additional 24 hours. The warm reaction mixture was allowed to cool, upon which the 
sodium ethoxide quickly crystalized from the solution. An attempt to isolate the product via filtration 
yielded extremely low yields even after extensive rinsing with toluene. An alternative isolation method 
was attempted by adding a small amount of water (to dissolve the sodium ethoxide) and quickly 
separating the aqueous and organic phase. Removal of the solvent yielded a yellow/brown residue.  
The FT-IR spectrum (Figure 2.13: D8) concluded that, although no nitrile was present as evident 
by the absence of the νCN at 2243 cm-1, a broad stretch in the region of 3294 cm-1 and several undefined 
bands around 1634 cm-1 indicate a mixture of amine and imine products were present. In the 1H NMR 
spectrum several undefined overlapping peaks were observed and the peak of interest, the aliphatic 
protons (f) which should resonate in the region of 3.6 ppm, could not be identified. Several resonances 
were observed in the range of 7.0 -7.5 ppm, which substantiate the observations made in the FT-IR 
spectrum, that a mixture of amine and imine products were present. Unfortunately, after several 
purification attempts the mixture of products was deemed inseparable. 
The synthesis of 4,4',4'',4'''-((1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrakis 
(methylene))tetrabenzonitrile (D9) has previously been reported by Comba.26 The first step is the 
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nucleophilic addition reaction between cyclam and 4-bromomethyl benzonitrile in a biphasic reaction. 
The product was extracted with chloroform before purification via recrystallization yielded the product 
as a white crystalline precipitate in moderate to high yields (≈ 80 % yield).  
 
Reaction Scheme 2.9: Synthesis of D9. 
The FT-IR spectrum (Figure 2.13: D9) displayed the absence of the νN-H stretch originating from 
cyclam while a sharp νCN stretch is now observed at 2223 cm-1. The 1H NMR spectrum showed a singlet 
resonating at 3.42 ppm integrating to 8 protons which correlate to the methylene protons (d) attached 
to the carbon in between the core and the benzene ring. These resonances were observed at 58.81 ppm 
(d) in the 13C NMR. The resonance corresponding to the aromatic carbons appear in the range of 145 – 
110 ppm (e-h) and the nitrile carbon was observed at 118.97 ppm (i). 
The sodium/ethanol and the Raney Ni reduction followed for D8 were also applied to D9 in an 
attempt to acquire (((1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrakis(methylene))tetrakis 
(benzene-4,1-diyl))tetramethanamine (D10).   
 
Reaction Scheme 2.10: Attempted synthesis of D10 
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The FT-IR spectra (Figure 2.13: D10) concluded the same results as observed before. D10 showed 
no νCN at 2223.88 cm-1 and broad stretches in the region of 3302.43 cm-1 and 1633.93 cm-1. The 1H 
NMR spectrum displayed several undefined overlapping peaks. The aromatic protons (e-f) were 
observed in their expected region of 7.0-7.5 ppm; however as with D8, the peak between the aromatic 
ring and the primary amine (i) could not be identified. Similar to D8, D10 most likely consisted of a 
mixture of amine and imine products which was inseparable.  
 
 
Figure 2.13: FT-IR spectra of D7 – D10. 
In summary, the nitrile reduction step for D8 and D10 discussed above was not successful. It seems 
the reduction does occur as there was no sign of the νCN stretch in their FT-IR spectra coupled with a 
clear change in the colour of the reaction mixture. However, various spots were observed on thin layer 
chromatography (TLC) and the NMR results could not be assigned unambiguously. Thus, it is likely 
that the reduction step was either incomplete or side reactions occurred to yield a mixture of products. 
Isolating the desired product was not successful via the work-up procedures attempted. It is known that 
the nitriles can be reduced via catalytic hydrogenation. However, neither the use of 5 % Pd/C or 5 % 
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Pt/C as a catalyst in methanol at 70 ºC and 20 bar H2 pressure showed complete reduction even after 
extended reaction time as previously proved by our group.23 An attempt to reduce D7 using Raney-
Nickel and sodium hydroxide with 15 bar H2 at 50 °C for 3 hours has previously been reported27, but 
unfortunately proved unsuccessful due to the pressure restriction that we were able to operate at. These 
catalytic reductions usually require higher pressure (> 50 bar). 
2.3 Conclusion 
In literature, PAMAM dendrimers are commonly used as scaffolds for various applications; 
however, most examples use commercially available dendrimers. In our case the aim was to incorporate 
a macrocycle at the core, which meant synthesizing the dendrimer from scratch. In our hands, half 
generation cyclam-cored PAMAM dendrimers could be synthesized via a microwave-assisted reaction. 
This simple method consistently yielded D1, D5 and D7 in high yields as air stable white solids in less 
than 1 hour compared to the conventional 3 days. D9 was obtained as a white solid following a biphasic 
method and the generation 1.5 cyclam-cored PAMAM dendrimer was obtained as a viscous yellow oil 
via the conventional method. The attempts at a microwave-assisted method for the amidation reaction 
were not successful, but full generation cyclam-cored PAMAM dendrimer D2 could be isolated via the 
conventional method in variable yields (40-90 % yields). The attempts to obtain higher generation 
cyclam-cored PAMAM dendrimer, D4, were unsuccessful and some evidence of cyclization was 
observed. Alternatively, using TACN as a core to reduce steric interactions in a bid to obtain higher 
generation TACN-cored PAMAM dendrimer, D6, was also unsuccessful. The PAMAM branches were 
prone to several side reactions, especially during the amidation step. Thus, an alternative route was 
envisaged where the Michael acceptor possessed a nitrile moiety which could subsequently be reduced 
to a primary amine. However, neither the cyclam-cored PPI (D7) nor BA (D9) dendrimers could be 
reduced to the corresponding amine derivatives (D8 and D10) and the crude consisted of a mixture of 
products due to incomplete reduction coupled with side reactions.  
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2.4 Experimental Section  
Solvents were obtained from Merck or Kimix and dried by distilling over the appropriate drying 
agents. Toluene was dried by distillation over sodium/benzophenone. Methanol was dried by distillation 
over magnesium turnings and iodine while dichloromethane was dried over phosphorus pentoxide. All 
reagents were purchased from either Sigma Aldrich or Merck and was used without any further 
purification.  
All Infrared spectra were recorded on a Thermo Nicolet Avatar 330 FT-IR spectrometer with a 
Smart Performer (Zn/Se) ATR attachment. 1H and 13C nuclear magnetic resonance spectra were 
recorded using a 300 MHz Varian VNMRS, 400 MHz Varian Unity Inova or 600 MHz Varian Unity 
Inova NMR instrument using deuterated solvents. Chemical shifts (δ) were recorded using the residual 
solvent peak or external reference (TMS). All chemical shifts are reported in parts per million and all 
spectra were obtained at 25 °C. Samples for EA analysis were done on a Perkin-Elmer 2400 Series II 
CHNS/O Elemental Analyzer at the University of Kwa-Zulu Natal. Mass spectra were recorded on a 
Waters Synapt G2 spectrometer. 
2.4.1 Synthesis of G0.5 cyclam-cored PAMAM dendrimer (D1) 
Cyclam (2.9970 g, 14.960 mmol) was dissolved in methanol (15 ml) before adding methyl acrylate 
(13.5 ml, 150 mmol) to the stirring solution. The reaction mixture was placed in the microwave reactor 
for 25 minutes at 38 °C controlled temperature with 50 W radiation. Once the reaction was completed 
the solvent and excess methyl acrylate was removed via rotary evaporator to afford a yellow oil. The 
oil was submerged in an ice bath before triturating with cold hexane to yield a white precipitate. The 
solid was filtered and dried under reduced pressure (D1: 8.042 g, 99 % yield). FT-IR (cm-1) ʋ(C=O) = 
1731 cm-1. 1H NMR (600 MHz, CDCl3) δ 3.64 (s, 12H, -C(O)O-CH3), 2.71 (t, 
3JH-H = 7.2 Hz, 8H, -N-
CH2-CH2-COO-), 2.47 (s, 8H, -N-CH2-CH2-N-), 2.44 (t, 
3JH-H = 6.8 Hz, 8H, -N-CH2-CH2-CH2-N-), 
2.40 (t, 3JH-H = 7.2 Hz, 8H, -N-CH2-CH2COO-), 1.53 (p, 
3JH-H = 6.8 Hz, 4H, -N-CH2-CH2-CH2-N-). 13C 
NMR (151 MHz, CDCl3) δ 173.3 (-COO-), 51.6 (-N-CH2-CH2-N-), 51.3 (-N-CH2-CH2-CH2-N-), 51.3 
(-N-CH2-CH2-COO-), 50.6 (-COO-CH3), 32.4 (-N-CH2-CH2-COO-), 24.1 ppm (-N-CH2-CH2-CH2-N-
).  
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2.4.2 Synthesis of G1 cyclam-cored PAMAM dendrimer (D2) 
To a stirring solution of D1 (6.406 g, 11.76 mmol) in dry methanol (20 ml) ethylenediamine (78.80 
ml, 1176 mmol) was added dropwise. The reaction mixture was stirred in the dark at room temperature 
for 5 days. The solvent and excess ethylenediamine was removed under reduced pressure to yield a 
yellow oil. The oil was purified by dissolving it in a minimum amount of methanol before transferring 
the yellow solution to a stirring solution of cold diethyl ether. After 2 hours, the off-white precipitate 
was isolated by removing the supernatant with a syringe. This purification method was repeated 3 times 
before drying the resulting product under reduced pressure. (D2: 7.714 g, 99 % yield). FT-IR (cm-1) 
𝜈(N-H) = 3294 cm-1, 𝜈(C=O) = 1628 cm-1.1H NMR (600 MHz, CDCl3) δ 7.57 (t, J = 5.4 Hz, N-H), 3.28 (dd, 
J = 11.7, 5.8 Hz, 8H, -C(O)-NH-CH2-CH2-NH2), 2.81 (t, J = 6.0 Hz, 8H, -C(O)-NH-CH2-CH2-NH2), 2.71 
(t, J = 6.5 Hz, 8H, -N-CH2-CH2-COO-), 2.55 (s, 8H, -N-CH2-CH2-N-), 2.49 (t, J = 6.9 Hz, 8H, -N-CH2-
CH2-CH2-N-), 2.34 (t, J = 6.5 Hz, 8H, -N-CH2-CH2-COO-), 1.65 (m, 4H, -N-CH2-CH2-CH2-N-). 13C NMR 
(101 MHz, CDCl3) δ 172.8 (C=O), 51.1 (-N-CH2-CH2-CH2-N-), 50.9 (-N-CH2-CH2-COO-), 50.4 (-N-CH2-
CH2-N-), 42.1 (-C(O)-NH-CH2-CH2-NH2), 41.6 (-C(O)-NH-CH2-CH2-NH2), 33.5 (-N-CH2-CH2-COO-), 
23.9 (-N-CH2-CH2-CH2-N-). Elemental analysis Calculated: N, 28.09; C, 48.17; H, 10.91 %; Experimental: 
N, 28.45; C, 48.85; H, 10.89 %. ESI-MS: [M + H]+ at 657 m/z. 
2.4.3 Synthesis of G1.5 cyclam-cored PAMAM dendrimer (D3) 
To a stirring solution of D2 (4.8896 g, 7.4432 mmol) in methanol (30 ml), methyl acrylate (67 ml, 
744 mmol) was added before stirring the reaction mixture in the dark for 5 days at room temperature. 
The solvent and excess methyl acrylate was removed under reduced pressure to obtain a yellow oil and 
further purified via kugel ruhr. (D3: Yellow oil, 8.510 g, 85 % yield). FT-IR (cm-1) ʋ(C=O)ester = 1728 
cm-1, ʋ(C=O)amide = 1644 cm-1, ʋ(N-H)stretch = 3308 cm-1. 1H NMR (300 MHz, CDCl3) δ 7.19 (t, J = 5.4 
Hz, 4H, N-H), 3.62 (s, 24H, -C(O)OCH3), 3.23 (dd, 8H, -C(O)-NH-CH2-CH2-N-), 2.72 (t, 
3JH-H = 6.7 
Hz, 16H, -N-(CH2-CH2-C(O)OMe)2), 2.68 (t, 8H, -C(O)-NH-CH2-CH2-N-), 2.51 (s, 8 H, -N-CH2-CH2-
N-), 2.49 (t, 8H, -N-CH2-CH2-C(O)-NH-), 2.44 (t, 8H, -N-CH2-CH2-CH2-N-), 2.38 (t, J = 6.7 Hz, 16H, 
-N-(CH2-CH2-C(O)OMe)2), 2.29 (t, J = 7.0 Hz, 8H, -N-CH2-CH2-C(O)-NH-), 1.60 (p, 
3JH-H = 6.8 Hz, 
4H, -N-CH2-CH2-CH2-N-). 13C NMR (101 MHz, CDCl3) δ 173.0 (s, -C(O)O-CH3), 172.3 (s, C(O) -
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NH), 53.0 (s, -N-CH2-CH2-CH2-N-), 52.2 (s, -N-CH2-CH2-C(O)NH-), 51.6 (s, -N-(CH2-CH2-C(O)O-
CH3)2), 51.5 (s, -N-CH2-CH2-C(O)NH-), 50.8, 50.2, 49.8 (s, -N-CH2-CH2-N-), 49.3 (s, -C(O)O-CH3), 
37.2 (s, -C(O)NH-CH2-CH2-N-), 33.2, 32.7 (s, -N-(CH2-CH2-C(O)O-CH3)2), 32.6 (s, -N-CH2-CH2-
C(O)O-NH-), 24.0 (s, -N-CH2-CH2-CH2-N). 
2.4.4 Synthesis of G2 cyclam-cored PAMAM dendrimer (D4) 
To a stirring solution of D3 (1.606, 1.194 mmol) in dry methanol (10 ml) ethylenediamine (8.00 
ml, 119 mmol) was added dropwise. The reaction mixture was stirred at in the dark at room temperature 
for 20 days. After 20 days the solution was filtered to isolate fine white precipitate. The solvent of the 
filtrate and the excess ethylenediamine was removed under reduced pressure to yield a yellow oil. The 
oil was purified dissolving it in a minimum amount of methanol before transferring the yellow solution 
to a stirring solution of cold diethyl ether. After 2 hours the off-white precipitate was isolated by 
removing the supernatant with a syringe. This purification method was repeated 3 times before drying 
the resulting product under reduced pressure. FT-IR (cm-1) 𝜈(N-H) = 3259 cm-1, 𝜈(C=O) = 1632 cm-
1.1H NMR (600 MHz, d2o) δ 3.67 (q, EtOH), 3.27 (t, J = 6.3 Hz, 8H, -C(O)-NH-CH2-CH2NH2), 2.81 
(t, J = 7.4 Hz, 8H, -C(O)-NH-CH2-CH2-NH2), 2.76 (s, EDA) 2.75 (t, 8H, -N-CH2-CH2-COO-), 2.67 (s, 
8H, -N-CH2-CH2-N-), 2.59 (t, 8H, -N-CH2-CH2-CH2-N-), 2.46 (t, J = 7.3 Hz, 8H, -N-CH2-CH2-COO-
), 1.68 (p, 4H, -N-CH2-CH2-CH2-N-), 1.20 (t, EtOH) 
2.4.5 Synthesis of trimethyl 3,3',3''-(1,4,7-triazonane-1,4,7-triyl)tripropanoate (D5) 
TACN (0.4229 g, 3.2791 mmol) was dissolved in dry methanol (5 ml) before adding methyl 
acrylate (2.22 ml, 24.5 mmol) to the stirring solution. The reaction mixture was placed in the microwave 
reactor for 25 min at a controlled temperature of 38 °C under 50 W radiation. The solvent and excess 
methyl acrylate was removed under reduced pressure to yield a colourless oil. (D5: 1.228 g, 97 % yield). 
FT-IR (cm-1) 𝜈(C=O) = 1733 cm-1. 1H NMR (600 MHz, CDCl3) δ 3.65 (s, 9H, -C(O)O-CH3), 2.81 (t, J 
= 7.2 Hz, 6H, -N-CH2-CH2-C=O), 2.67 (s, 12H, -N-CH2-CH2-N-), 2.42 ppm (t, J = 7.1 Hz, 6H, -N-
CH2-CH2-C=O). 13C NMR (151 MHz, CDCl3) δ 173.4 (C=O), 55.6 (-N-CH2-CH2-N-), 54.2 (-C(O)O-
CH3), 51.6 (-N-CH2-CH2-C=O), 33.4 (-N-CH2-CH2-C=O). 
Stellenbosch University  https://scholar.sun.ac.za
Synthesis and Characterization of Cyclic cored PAMAM, PPI and BA Dendritic Ligands 
64 
 
2.4.6 Synthesis of 3,3',3''-(1,4,7-triazonane-1,4,7-triyl)tris(N-(2-aminoethyl) propanamide) 
(D6) 
D5 (0.370 g, 0.955 mmol) was dissolved in methanol (5 ml) before adding ethylenediamine (5.8 
ml, 84 mmol) to the stirring light yellow solution. The reaction mixture was allowed to stir at room 
temperature for 5 days in the dark before removing the solvent via rotary evaporator to afford a yellow 
oil. The oil was further dried on the kugelrogh at 45 °C for 2 hours. The oil was dissolved in methanol 
and after a week some crystals were observed, isolated and dried for analysis. FT-IR (cm-1) 𝜈(C=O) = 
1637 cm-1, 𝜈(N-H stretch) = 3256 cm-1, 𝜈(N-H bend) = 1461 cm-1, 𝜈(C-N) = 1547 cm-1. 1H NMR (600 
MHz, d2o) δ 3.32 (t, J = 5.7 Hz, 8H, -N-CH2-CH2-C(O)-O-NH-CH2-CH2-NH2), 3.08 (t, J = 5.7 Hz, 8H, 
-N-CH2-CH2-C(O)-O-NH-CH2-CH2-NH2), 2.99 (s, 8H, -N-CH2-CH2-N-). 
2.4.7 Synthesis of 3,3',3'',3'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl) 
tetrapropanenitrile (D7) 
Cyclam (0.193 g, 0.963 mmol) was dissolved in methanol (5 ml) before adding acrylonitrile (0.64 
ml, 9.6 mmol) to the stirring solution. The reaction mixture was placed in the microwave reactor for 25 
minutes at 38 °C controlled temperature with 50 w radiation. The solvent and excess acrylonitrile was 
removed under reduced pressure. The resulting white precipitate was dissolved in a small amount of 
warm chloroform before placing the solution in the freezer overnight. The white crystalline precipitate 
was isolated via filtration and dried under reduced pressure. (D7: 0.3298 g, 83 % yield) FT-IR (cm-1) 
νCN = 2243 cm-1. 1H NMR (600 MHz, CDCl3) δ 2.75 (t, J = 6.7 Hz, 8H, -N-CH2-CH2-CN), 2.62 (s, 8H, 
-N-CH2-CH2-N-), 2.57 (t, J = 6.7 Hz, 8H, -N-CH2-CH2-CN), 2.44 (t, J = 6.7 Hz, 8H, -N-CH2-CH2-
CH2-N-), 1.63 (p, 4H, -N-CH2-CH2-CH2-N-). 13C NMR (151 MHz, CDCl3) δ 119.3 (-N-CH2-CH2-CN), 
51.8 (-N-CH2-CH2-N-), 51.4 (-N-CH2-CH2-CN), 50.3 (-N-CH2-CH2-CH2-N-), 24.8 (-N-CH2-CH2-
CH2-N-), 16.5 (-N-CH2-CH2-CN). 
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2.4.8 Attempted Synthesis of 3,3',3'',3'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-
tetrayl)tetrakis(propan-1-amine) (D8) 
To a stirring solution of D7 (0.6079 g, 1.4737 mmol) in dry toluene (25 ml) small pieces of sodium 
metal (±10 g) was added and the reaction mixture was stirred under reflux under a nitrogen atmosphere 
for 20 hours. Thereafter, 50 ml dry ethanol was added during the course of three hours. After an 
additional 24 hours of stirring under reflux, the solution was allowed to cool to room temperature upon 
which sodium ethoxide crashed out of solution. Distilled water (30 ml) was added and the mixture was 
swiftly swirled before separating the organic and aqueous phase via a separating funnel. The organic 
phase was dried over potassium carbonate, before removing the solvent under reduced pressure to yield 
a brown oil.  
2.4.9 Synthesis of 4,4',4'',4'''-((1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrakis 
(methylene))tetrabenzonitrile (D9) 
Cyclam (0.5024 g, 2.5109 mmol) and sodium hydroxide (0.3715 g, 9.2886 mmol) was dissolved 
in distilled water (80 ml), before adding a solution of 4-bromomethyl benzonitrile (1.9682 g, 10.044 
mmol) in chloroform (10 ml). The reaction mixture was vigorously stirred at room temperature for 7 
hours. Once completed, the organic phase was separated and dried over MgSO4, before removing the 
solvent to afford a white precipitate. The precipitate was purified via recrystallization from DCM 
solution layered with MeOH and placed in the freezer overnight. The resulting precipitate was isolated 
via filtration and dried under reduced pressure. (D9: 1.1895 g 71 % yield). FT-IR (cm-1) νCN = 2223 cm-
1. 1H NMR (600 MHz, CDCl3) δ 7.53 (d, J = 8.2 Hz, 8H, Ar-H), 7.40 (d, J = 8.2 Hz, 8H, Ar-H), 3.42 (s, 8H, N-
CH2-C6H4-), 2.57 (s, 8H, -N-CH2-CH2-N-), 2.46 (t, J = 6.9 Hz, 8H, -N-CH2-CH2-CH2-N-), 1.74 (m, 4H, -N-
CH2-CH2-CH2-N-). 13C NMR (101 MHz, CDCl3) δ 145.9 (N-CH2-Ar), 132.0 (Ar-H), 129.3 (Ar-H), 118.9 (Ar-
CN), 110.8 (Ar-CN), 58.8 (N-CH2-C6H4-), 51.5 (-N-CH2-CH2-N-), 50.6 (-N-CH2-CH2-CH2-N-), 24.4 (-N-
CH2-CH2-CH2-N-). 
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2.4.10 Attempted Synthesis of (((1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrakis 
(methylene))tetrakis(benzene-4,1-diyl))tetramethanamine D10 
To a stirring solution of D7 (0.6079 g, 1.4751 mmol) in dry toluene (25 ml) small pieces of sodium 
metal (±10 g) was added and the reaction mixture was stirred at reflux under nitrogen atmosphere for 
20 hours. Thereafter, 50 ml dry ethanol was added during the course of three hours. After an additional 
24 hours of stirring at reflux the solution was allowed to cool to room temperature upon which sodium 
ethoxide crashed out of solution. Distilled water (30 ml) was added and the mixture was swiftly swirled 
before separating the organic and aqueous phase via a separating funnel. The organic phase was dried 
over potassium carbonate, before removing the solvent under reduced pressure to yield a brown oil. 
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3 Synthesis and Characterization of Dendritic Cu (II) and Ga (III) complexes 
3.1 Introduction 
In chapter 3, α–amino phosphonic acids are introduced with special focus on the chemical aspects 
contributing to their unique properties. It covers the relevant synthetic methods commonly employed to acquire 
these target ligands and complexes. The attempted modification of generation 1 cyclam-cored 
poly(amidoamine) PAMAM dendrimer (D2) to form a phosphonic acid analogue (L1) is described followed 
by the isolation of multinuclear gallium (III) complex (C1). A set of model ligands (ML1 and ML2) as well 
as a model complex (MC1) were synthesized for comparison with the multinuclear derivatives. Commercially 
available generation 1 diaminobutane poly(propylenimine) DAB-PPI was also modified to obtain the 
corresponding phosphonic acid analogue (L2). In addition, chapter 3 also covers the versatility of Schiff base 
ligands. The synthesis of a salicylaldimine derivative (L3) and the isolation of the corresponding gallium (III) 
(C4a and C4b) and copper (II) (C5) complexes are reported. These ligands and complexes were selected as 
prospective multinuclear scaffolds for “cold” analogues of dendritic radiotracers which could potentially be 
employed for cancer diagnosis.  
 
Figure 3.1: General structure of target ligands. 
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3.2 α–Aminophosphoryl compounds 
α–Amino phosphoryl compounds have recently attracted the attention of researchers from a wide array 
of disciplines. These versatile compounds have proved their worth in several fields as evident from their range 
of applications (discussed in Chapter 1: Section 1.2.3.1). The impetus to investigate α–amino phosphonic acids 
(1) (depicted in Figure 3.2) stems from the similarities they share with α–amino acids.  
 
Figure 3.2: α–Amino phosphonic acids. 
Considering that nitrogen and phosphorous are both p-block elements located in the second and third 
period of group 15, respectively, it is expected that they should behave similarly. However, fundamental 
differences in their reactivity are observed. The unique electronic configurations of each element determines 
their size, shape, and acidity1, all of which are influential in their reactivity. 
Phosphorous compounds commonly exist either as trivalent or pentavalent compounds with a range of 
possible oxidation states (-3 to +5) available, whereas nitrogen can only be regarded as trivalent. The difference 
in s-d promotional energy of phosphorous (3s → 3d) is less than that of nitrogen (2s → 3d). In other words, 
the valence electrons of phosphorous occupy higher energy levels in comparison to that of nitrogen. Thus, it 
is common for phosphorous to access these d orbitals to assist in bonding and facilitate hybridization. 
Phosphorous often forms multiple bonds between itself and oxygen involving dπ (P) – pπ (O) interactions to 
form the all-important phosphoryl (P=O) bond.2 The phosphoryl bond is polarized and the oxygen atom 
possesses a sterically accessible lone electron pair, however the substituents on the phosphorous atom have the 
greatest influence on the overall reactivity. 
Phosphoric acid (2) consists of three P-OH moieties and one phosphoryl (P=O) bond. Alkyl or aryl 
phosphonic acids (3) are considered derivatives of 2 in which case an organic moiety R replaces a hydroxyl 
moiety. The phosphorous atom is sp3 hybridized ensuring the PO3-C moiety adopts a tetrahedral geometry. 
The two acidic P-OH groups have different pKa values (pKa1 = 0.5 – 3, pKa2 = 5 – 9).1 The wide pKa range of 
the diprotic acid is due to the extent of electron-withdrawing or electron-donating abilities of the organic 
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substituent.3 Phosphonates (4) are ester analogues of 2, in which all three acidic hydroxy moieties are replaced 
by alkoxy units (OR). With this said, these species require an introduction as they are a common intermediate 
towards the synthesis of 3 (Figure 3.3). 
 
Figure 3.3: (2) Phosphoric acid (3) Phosphonic acid (4) Phosphonates. 
This following section introduces the chemical relevance of phosphorous compounds and their respective 
α–aminophosphorous derivatives. The discussion entails a brief overview of various synthetic methods, 
reaction parameters and purification techniques commonly encountered, with special focus given to the Irani-
Moedrizner and Pudovik reactions. 
3.3 Typical synthetic routes to α–Aminophosphoryl compounds 
Developing a synthetic procedure that affords α–aminophosphonic acid that contain the valuable N-C-P 
fragment, has been under the spotlight due to their intriguing biological potential. Various avenues have been 
explored and several review articles showcase the synthetic advancement achieved over the years.4  
3.3.1 Michaelis – Arbuzov Rearrangement 
The most direct route to form a C-P bond is known as the Michaelis–Arbuzov Rearrangement (Figure 
3.4) which was first reported by Michaelis5, and has been thoroughly investigated by Arbuzov.6,7 The simplest 
example of this well-known method entails a nucleophilic trialkyl phosphite (5) reacting in a SN2 fashion with 
an halide (6) via an alkoxy phosphonium salt intermediate (7) to yield dialkyl alkyl phosphonate (8) and the 
resultant alkyl halide (9). The reaction tends to require heating under reflux.  
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Figure 3.4: Michaelis – Arbuzov Rearrangement. 
3.3.2 Michaelis–Becker reaction 
Alternatively, the Michaelis–Becker reaction (Figure 3.5) requires less stringent reaction temperatures as 
compared to the Michaelis–Arbuzov reaction. The reaction involves the nucleophilic substitution between a 
phosphorous component (10), which when treated with a base exists as 11, and a haloalkane (7) to yield 
phosphinates/phosphonates (12). The ambident nature of the nucleophile, coupled with the basicity of the salt, 
makes it susceptible to side reactions. 
 
Figure 3.5: Michaelis–Becker reaction (10 and 11: R2/R3 = alkyl, 12: Phosphinates: R2/R3 = alkyl derivative; Phosphonates: R2/R3 = 
alkoxy derivative). 
3.3.3 Kabachnik-Fields reaction 
Alternatively, phosphonates can be obtained by means of a Mannich-type condensation reaction (Figure 
3.6). However, preceding work done by Abramov and Pudovik is worth mentioning first. Abramov8 was able 
to synthesize α-hydroxy phosphonates (18) through the addition of dialkyl phosphite (15) to a carbonyl moiety 
(13). Two years later, Pudovik9 synthesized α-amino phosphates (16) by reacting the substrate containing a P-
H bond with the carbon of an imine moiety. The Kabachnik-Fields reaction, a phospha-Mannich type variation, 
was independently discovered by Kabachnik and Medved10 and Fields.11 The one-pot, three component 
reaction involves aldehydes or ketones12 as the carbonyl compound (13), an amine (14) and a dialkyl phosphite 
(15) as the activated substrate. The exact mechanism for the Kabachnik-Fields reaction is still under dispute. 
Two possible pathways have been proposed13; the “imine route” and the “α–hydroxy phosphonate route”, 
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which has been named according to the intermediates which are formed. The preferred pathway seems to 
depend on the nature of the substrates.14,15 During the reaction, the soft nucleophile 15 and the hard nucleophile 
14 compete for the electrophilic carbonyl compound 13. The first pathway (imine route) involves the Schiff 
base reaction between 13 and 14 followed by the addition of the crucial activated substrate 15 to the imine 17 
via a Pudovik-type reaction to yield an α-amino phosphonate species (16). This route is usually favoured by a 
hard carbonyl compound and dependent on the basicity of the amine.16 This is contradictory to the hydroxy 
phosphonate route which involves the addition of the activated species 15 to the carbonyl compound 13. This 
results in the formation of hydroxy phosphonate 18 which subsequently undergoes direct nucleophilic 
substitution with 14 to afford the α-amino phosphonate species 16. In this case, a softer carbonyl compound is 
preferred.16  
 
Figure 3.6: Kabachnik-Fields Reaction. 
3.3.4 Irani-Moedritzer reaction 
A particular case of the Kabachnik-Fields reaction, known as the Irani-Moedritzer reaction, (Figure 3.7), 
specifically utilizes phosphorous acid (20) and formaldehyde (21) in combination with the desired amines (19) 
to yield α-amino phosphonic acids (22). The synthetic procedure which K. Moedritzer and R. R. Irani17 
employed, provides a method to yield phosphonic acids directly avoiding the additional hydrolysis step 
required during the Kabachnik-Fields reaction. The Irani-Moedritzer reaction only succeeds in an acidic 
medium with formaldehyde as the carbonyl compound. The low pH increases the reaction rate, improves yields 
and limits the oxidation of phosphites to phosphates. 17 
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Figure 3.7: Irani-Moedritzer reaction. 
3.4 Results and discussion 
The Irani-Moedritzer reaction was considered as a viable method to modify the cyclam-cored PAMAM 
dendritic scaffold (D2, reported in Chapter 2) to its corresponding phosphonic acid derivative. Turrin and co-
workers18 showed that the Irani-Moedritzer procedure could successfully modify amino terminated 
poly(ethylene glycol) (PEG) ranging from 750 – 5000 g.mol-1 in one step to the corresponding 
bis(phosphonomethyl)amino analogues (Figure 3.8a). More recently, Lui and co-workers19 investigated the 
dispersion properties of a series of bis(phosphonic acid)amino-terminated polymers which they were able to 
synthesize via the Irani-Moedritzer reaction (Figure 3.8b). 
 
Figure 3.8:(a) bis(phosphonomethyl)amino-terminated poly(ethylene glycol)18,  
(b) bis(phosphonic acid)amino-terminated polymers.19 
 
The research by Zeevaart et al.20 details the synthesis of a water-soluble polymer functionalized with 
methylene phosphonate groups (PEI-MP) which indicates that the Irani-Moedritzer procedure allows for the 
transformation of secondary and primary amines.  
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Figure 3.9: Water-soluble polymer functionalized with methylene phosphonate groups (PEI-MP). 20 
 Drawing inspiration from their method, we set out to functionalize the cyclam-cored PAMAM dendrimer 
D2 to produce a phosphonic acid modified dendrimer L1. This was attempted using a direct approach via the 
Irani-Moedritzer method. 
3.4.1 Synthesis and characterization of phosphonic acid modified Cyclam cored PAMAM (L1) and 
the subsequent multinuclear Ga (III) complex (C1) 
The strategy employed to functionalize the dendritic scaffold D2 to a multifunctional ligand L1 was done 
according to a modified procedure first described by Irani-Moedritzer17 (Reaction Scheme 3.1). The reaction 
was attempted under various experimental conditions, varying temperature, time and reagent ratios in order to 
establish the optimum conditions.  It is known that in acidic media (pH < 4) the reactive phosphonic acid 
species suppress the side reactions that can occur, such as N-methylation of free amino groups.21 The mol 
ratios of reagents were determined based on the prediction that both primary amine and secondary amine sites 
could possibly react, as it has been shown that secondary amines are normally more reactive than primary 
amines in the Irani-Moedritzer reaction.17 However, with the correct molar ratios, Li et al.22 describe the 
modification of only the peripheral primary amines to produce the ethylenediamine cored, 
octamethylenephosphonic acid terminated PAMAM dendrimers. Sherry23 studied the effect of temperature, 
the molar ratios of the reactants, total volume of the reaction mixture, acidity, addition time of 
paraformaldehyde, and total reaction time as well as the order of addition during the synthesis of 1, 4, 7, 10-
tetraazacyclododecane-1, 4, 7, 10-tetrakis(methylene phosphonic acid) (DOTP). The findings concluded that 
no more than 50 % excess paraformaldehyde and 100 % phosphorous acid were needed. The optimal time for 
addition of paraformaldehyde was 1 hour and the optimal reflux time following the complete addition of 
paraformaldehyde was also 1 hour.  
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Accordingly, in our case 15 mol equivalents of phosphorous acid were added to a stirring solution of 
dendrimer D2, before adding 18 mol equivalents of formaldehyde under acidic conditions. The reaction was 
stirred at 90 – 110 °C under a nitrogen atmosphere for a total of 4 hours. The crude product was isolated after 
removal of the solvent. The yellow oil obtained was found to be water-soluble and only partially soluble in 
polar organic solvents. Several purification methods were attempted such as recrystallization, acid-base 
extraction, lyophilization (freeze drying), and isolation of the salt adduct; however, isolation was hindered by  
 
Reaction Scheme 3.1: Synthesis of L1. 
the lack of solubility that L1 exhibited in organic solvents. Alternatively, compounds with sufficiently high 
molecular weights could also be purified via dialysis, size exclusion chromatography (SEC) and  high-
performance liquid chromatography (HPLC).24 The best purification strategy was found when a saturated 
solution of the crude product in water, was decanted into cold ethanol while vigorously stirring the solution. 
A white precipitate immediately crashed out of solution. The white precipitate was isolated via filtration under 
nitrogen. The precipitate was hygroscopic in nature and without a nitrogen atmosphere the precipitate quickly 
becomes an undesirable sticky substance.  
The FT-IR spectrum of L1 showed the expected νP=O absorbance at 1168 cm-1 and the νP-O-H stretch, which 
appears as two peaks at 918 and 1034 cm-1. The νP-O-H stretch was also observed at 3354 cm-1. The bands 
observed at 1720 cm-1 can be assigned to the amide νC=O stretch with some evidence of νN-H stretch between 
3400 – 3200 cm-1. The 1H NMR spectrum of L1 displayed the acidic protons (P-OH) as two singlets in the 
expected region between 6 – 8 ppm and a distinct doublet at 3.37 ppm corresponding to the resonances for the 
methylene protons on the carbon connecting the phosphorous and nitrogen (h in Reaction Scheme 3.1). The 
N-CH2-P resonance exhibited 2JP,H = 14 Hz coupling which is common for these compounds.25 Although these 
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results indicate the formation of the N-C-P bond, the resonances originating from the dendrimer showed 
extensive overlap of broad undefined peaks in the range of 1 – 4 ppm. The protons of the macrocyclic moiety 
represented by a in Reaction Scheme 3.1 appear as a broad peak at 1.29 ppm. Two other regions around 3.58 
and 3.18 ppm seem to be a combination of protons d/f and e/g, respectively. Several smaller peaks are observed, 
but could not be identified which may indicate a product mixture or an impure product. The 13C NMR spectrum 
of L1 indicated several peaks in the region of 173 ppm where a single peak representing the amide carbon is 
expected. This may indicate that not all internal NH groups are phosphorylated. Also, multiple peaks appear 
between 55 – 30 ppm which could not be assigned unambiguously. The peak at 49.45 ppm was assigned to the 
methylene carbon (h in Reaction Scheme 3.1) connecting the phosphorous and nitrogen. Further 
characterization via 31P NMR is expected to show two singlets, one for internal and one for peripheral 
phosphorous environments in the region of 8 ppm. However, there were several peaks in the range of 0.5 - 
20.00 ppm. Three peaks at 8.84, 7.27 and 3.36 ppm were assigned to the two different phosphorous 
environments and the starting material, respectively.  
Further characterization of L1 included elemental analysis. The results obtained from the elemental 
analysis indicated that the experimental values (N, 11.33; C, 25.45; H, 7.09 %) did not correlate with the 
calculated values (N, 9.42; C, 28.26; H, 5.65 %). However, the hygroscopic nature of these dendritic ligands 
has a propensity to trap solvent molecules and with the addition of several water molecules both the calculated 
values for carbon and hydrogen started to correlate with the experimental results. The calculated nitrogen value 
could not be lowered by the addition of any solvent or reagent used during the experiment. The calculated % 
value of nitrogen could only be lowered if some of the internal NH groups were not phosphorylated. Thus, 
from elemental analysis it seems there is a mixture of products (i.e. mixture of complete and partially 
phosphorylated dendrimer) as well as some encapsulated solvent molecules. 
Additionally, L1 was analysed by electrospray ionization mass spectrometry (ESI-MS). This technique 
provides soft ionization which allows for the preferential detection of multiply charged species rather than 
fragmentations, although such fragmentations are not entirely absent. The number of basic sites on the 
molecule usually refers to the number of possible charged species that can form. Therefore, the peak assigned 
to the singly charged parent ion is often absent for macro-molecules, instead various multiply-charged 
molecular ions or some adducts thereof are observed. As a result, the analysis of ESI-MS can be complex for 
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large molecules, especially in the range 200 m/z – 1000 m/z and although to a lesser extent, it is common to 
encounter several complex fragmentation patterns. In the positive mode ESI MS spectrum of L1, the peaks 
observed at m/z ratio of 489.29, 511.25 (base peak) and 533.21 corresponds to the triply charged molecular 
ion that lost four PO3H2 fragments [C42H94N12O28P8]3+ and their sodium adducts [C42H94N12O28P8 + Na]3+ and 
[C42H94N12O28P8 + 2Na]3+, respectively. The base peak appeared at m/z ratio of 355.02 and was assigned to the 
potassium adduct of one pendent arm with the additional loss of a PO3H2 fragment [C8H18N2O7P2 + K - H]-.  
The isolation, purification and characterization of the dendritic ligand proved to be challenging due to the 
hygroscopic nature and solubility properties of the crude product. The characterization indicated that L1 had 
been synthesized, but suggest that several impurities were still present after various purification steps. The 
material isolated was most likely a mixture of products as the reagents were removed during the work-up 
procedure. Being unable to obtain a pure ligand, the crude material was directly employed in a complexation 
reaction with gallium chloride with the aim of isolating the multinuclear complex C1 from the reaction mixture.  
Gallium (III) is regarded as a small, highly charged (i.e. hard) metal ion and exhibit properties closely 
related to iron (III). In literature, there are copious examples of gallium-macrocyclic complexes especially 
those based on 1,4,7,10-tetraazacyclododecane (Cyclen) and 1,4,7-triazacyclononane (TACN). These show 
high thermodynamic stability and kinetic inertness. The latter, TACN derivatives, are more suitable chelators 
as the size of the coordination cavity corresponds better to the size of Ga (III) resulting in a near perfect 
octahedral coordination sphere.26 TACN derivatives show a slower rate of complex formation compared to 
open-chain ligands due to a higher activation barrier, but open-chain ligands on the other hand show a lower 
degree of kinetic stability.27  
According to our knowledge, no literature has been reported on the complex C1, which has four PAMAM 
branches each containing three phosphonic acid chelators. Thus, L1 with a total of 12 phosphonic moieties 
was reacted with 18 mol equivalents of gallium trichloride in an attempt to isolate the multinuclear complex. 
The crude (L1) was suspended in warm ethanol before adding the metal salt. The reaction mixture was stirred 
at reflux for 24 hours before decanting the warm solution into a cold diethyl ether solution. The resulting white 
precipitate was isolated via filtration, rinsed with cold diethyl ether and dried to yield C1 (Reaction Scheme 
3.2).  
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Reaction Scheme 3.2: Synthesis of C1. 
After complexation, the FT-IR spectrum of C1 showed a shift in the νP=O stretch to higher wavenumbers 
from 1168 cm-1 (L1) to 1201 cm-1 (C1). Another indication of complexation can be seen when monitoring the 
νP-O-H stretch, which appears as two absorptions at 918 and 1034 cm-1 for L1 but coalesced into one peak at 
1007 cm-1 for C1. The two bands seen for L1 are due to the νP-O-H(symmetric) and νP-O-H(asymmetric) stretches, 
which after complexation through one of the P-O bonds, appear as a single band in the spectrum of C1. The 
νP-O-H stretch also displayed a shift to higher wavenumbers from 3236 cm-1 (L1) to 3554cm-1 (C1). The amide 
νC=O stretch shifted slightly lower to 1719 cm-1 after complexation.28 Further characterization by 1H NMR 
displayed the acidic protons (P-OH) resonating as singlets in the range of 6 – 8 ppm as expected and the 
methylene protons on the carbon connecting the phosphorous and nitrogen (N-CH2-P) appeared downfield 
relative to L1 at 3.6 ppm with 2JP,H = 12 Hz coupling. The spectra showed several peaks in the range of 1 - 4 
ppm; however, no definitive assignment was possible due to broad peaks overlapping extensively. The 31P 
NMR spectrum showed a broad peak at 4.41 ppm, which could be assigned to the phosphorous acid reagent. 
The region of interest between 10 -7 ppm shows 5 peaks which seems like two broad triplets overlapping. 
These are assigned to the two different phosphorous environments. There also appears a broad peak at 17.92 
ppm, which could possibly be evidence that some arms are uncoordinated. 
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Figure 3.10: FT-IR of Dendrimer (D2 – Blue), Phosphonic acid derivative (L1 – Red), Gallium complex (C1 – Green). 
Further characterization of C1 included elemental analysis and electrospray ionization mass spectrometry 
(ESI-MS). The results obtained from the elemental analysis indicated that the experimental values (N, 7.18; 
C, 21.00; H, 5.38 %) corresponded well with the calculated values (N, 6.99; C, 20.98; H, 3.69 %). The 
difference in the hydrogen could not be accounted for, even with the inclusion of various solvent molecules 
which the hygroscopic product was expected to encapsulate within the dendrimer matrix. 
Electrospray ionization mass spectrometry (ESI-MS) was again used to analyse C1. In the positive mode 
ESI MS spectrum of C1 the peaks observed at m/z ratio of 511.25 (base peak) and 533.21 originates from L1 
and was discussed above. The peak observed at m/z ratio of 357.04 corresponds to the fragment depicted in 
Figure 3.11.   
 
Figure 3.11: Positive mode ESI MS fragment of C1. 
D2 
L1 
C1 
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3.4.2 Synthesis and characterization of phosphonic acid model ligands and complexes 
A set of model ligands (ML1 and ML2) and complexes (MC1 and MC2) was synthesized to compare 
the mono- and bi- nuclear variations of the multinuclear dendritic ligand L1 and complex C1. These model 
ligands and complexes also provided some insight to the behavior of the molecule under the standard reaction 
conditions employed for L1 and C1.  
3.4.2.1  Synthesis and characterization of model ligand 2 (ML2)  
The first two reaction steps towards ML2 (Reaction Scheme 3.3) were based on the synthetic method 
followed to obtain D2. The microwave-assisted Michael addition produced mono- and disubstituted products 
and had to be purified via silica gel chromatography (DCM: MeOH 9:1) to yield dimethyl 3,3'-
(propylazanediyl)dipropanoate ML2a as a clear oil (3.049 g, 74 % yield). G. Bosica et al.29 also observed the 
formation of a mixture of products and concluded that the reactivity of the Michael donors depends on its 
electronic nature i.e. the length of the alkane chain bonded to the nitrogen and also the nature of the amine 
(primary/ secondary). This essentially indicated that the propyl amine has less electron density than the 
PAMAM branch, because only the formation of bis substituted was seen during the synthesis of D2, as 
described in Chapter 2. Amidation of ML2a yielded 3,3'-(propylazanediyl)bis(N-(2-aminoethyl)propanamide) 
ML2b in high yield (3.012 g, 79 % yield) as a clear oil.  The final step was the modification of ML2b via the 
Irani-Moedritzer reaction in an attempt to isolate ML2. The latter was chosen as a representation of two of the 
PAMAM branches as a di-nuclear analogue. The reaction conditions were the same as described for L1 and 
ML2 was isolated as a yellow viscous solid (0.421 g, 77 % yield). 
The reaction was followed via FT-IR (Figure 3.12) and 1H NMR. ML2a displayed an absorption at 1732 
cm-1 corresponding to νC=O stretch of the ester moieties which shifted to lower wavenumbers in ML2b to 1636 
cm-1 now corresponding to the νC=O stretch of the amide moiety. Upon phosphorylation, the spectrum of ML2 
displayed broad peaks corresponding to the νP=O stretch and νP-O-H stretch at 1142 and 911 cm-1, respectively. 
The νC=O stretch shifted to higher wavenumbers from 1636 to 1710 cm-1. The large shift to higher wavenumbers 
was also observed for L1, and was thought to be due to the electron withdrawing moiety added to the amide 
nitrogen. 
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Reaction Scheme 3.3: Synthesis of ML2. 
 
 
Figure 3.12: FT-IR of ML2a – Blue; ML2b – Red; ML2 – Purple. 
In the 1H NMR spectrum of ML2a the methoxy protons (g in Reaction Scheme 3.3) resonated as a singlet 
at 3.63 ppm integrating to a total of 6 protons. This peak disappeared upon amidation as evident from the 
spectrum obtained for ML2b. For ML2b the methylene protons (g in Reaction Scheme 3.3) adjacent to the 
amide nitrogen resonated as a triplet at 3.24 ppm with 3JH,H = 6.3 Hz coupling and integrating for a total of 4 
ML2a 
ML2b 
ML2 
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protons. The spectrum of ML2 showed evidence of the acidic protons (P-OH) between 6 – 8 ppm and several 
overlapping peaks in the region of 2.5 – 4.0 ppm. The doublet appearing at 3.57 ppm was assigned to the 
methylene protons on the carbon connecting the phosphorous and nitrogen (N-CH2-P). The 13C NMR of ML2a 
showed the methoxy carbon (g in Reaction Scheme 3.3) resonating at 49.29 ppm and the carbonyl carbon (f in 
Reaction Scheme 3.3) at 172.96 ppm. The subsequent amidation had no significant effect on the carbonyl 
chemical shift as it appeared at 172.86 ppm for ML2b. However, the absence of the methoxy carbon and the 
appearance of two new peaks at 41.45 and 42.01 ppm corresponding to the carbons g and h in Reaction Scheme 
3.3 indicated that the amidation was successful. It should be noted that the spectra of ML2b had several small 
peaks in the range of 22.00 – 54.00 ppm.  
The results indicate that the phosphorylation was successful, however, separation of the product from the 
reaction mixture was not achieved. The cause of this reaction mixture was thought to be from several sources. 
During the amidation reaction some remaining ethylenediamine (EDA) could also undergo phosphorylation 
and both the products of EDA and ML2b could yield incomplete amine sites. During the phosphorylation 
reaction, it was suspected that under the harsh reaction conditions, the amide moiety hydrolyzed, contributing 
to the mixture of possible products (Figure 3.13).  
 
Figure 3.13: Possible hydrolysis products. 
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A quick test was done by boiling D2 in acidic water and it was found that within 2 hours hydrolysis 
occurred30 as evident from νC=O absorption of the carboxylic acid carbonyl at around 1700 cm-1 monitored via 
FT-IR spectroscopy. The goal was to separate the fractions formed during the synthesis of ML2, but 
unfortunately the separation, as with L1, was not successful after several attempts.  
3.4.2.2 Synthesis and characterization of model ligand 1 (ML1) and model complex 1 (MC1) 
The monodentate derivative (ML1) was chosen to represent the tertiary amine fractions of L1 and was 
prepared following a method reported by Gholivand and co-workers.31 Propyl amine was transformed to 
((propylazanediyl)bis(methylene))diphosphonic acid (ML1) via a Irani-Moedritzer reaction to yield a clear oil 
which was further purified by crystallization from methanol. The precipitate was isolated as a white solid under 
nitrogen in moderate to high yields (80 %). Thereafter, gallium trichloride was added to a stirring suspension 
of ML1 in dry methanol. Upon addition, the milky white solution immediately became clear pink, gradually 
changing to purple after 1 hour. The reaction mixture was stirred for an additional 12 hours during which the 
solution became milky white. After work-up, MC1 was isolated as a white air-stable powder (75 % yield). The 
complete reaction scheme is represented in Reaction Scheme 3.4.  
 
Reaction Scheme 3.4: Synthesis of MC1. 
 
In the FT-IR spectra (Table 3.11) of the ML1, the absorption observed at 1133 cm-1 represents the νP=O 
stretch. Further characterization by 1H NMR of ML1 (Figure 3.14a), showed the methylene protons (d in 
Reaction Scheme 3.4) resonating at 3.45 ppm as a doublet due to 2JH-P = 12.8 Hz coupling. The resonance 
corresponding to the protons represented by c in Reaction Scheme 3.4 deviates from its expected triplet, and 
can be observed as a multiplet at 3.32 ppm due to 4JH,P coupling. The 13C NMR spectrum of ML1 (Figure 
3.14b) depicts the methylene carbon (d) resonating at 51.67 ppm as a doublet of doublets due to 1JC-P = 137.8 
Hz and 2JH-P = 4.4 Hz coupling. The resonance corresponding to c can be seen as a triplet at 59.02 ppm due to 
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3JC-P = 3.8 Hz coupling. The 31P NMR (Figure 3.14c) displayed a singlet at 8.85 ppm, which differs from that 
of the starting material at 5.42 ppm. The elemental analysis results of ML1 indicated that the compound 
consisted of N, 5.67; C, 24.30 and H, 6.12 %. These results correspond to the calculated value for C5H15NO6P2 
which are N, 7.29; C, 22.63 and H, 6.64 % with the addition of a single water molecule. However, the 
difference for nitrogen increases which may possibly be due to the nitrogen standard used during calibration. 
There are no compounds/reagents used during the reaction or work-up procedure that can account for the 
difference in nitrogen. The ESI MS(-) spectra of ML1 showed a base peak at 246 m/z which corresponds to 
the molecular ion without a hydrogen [M - H]-.  
 
Figure 3.14:  NMR spectra of ML1: a) 1H NMR; b)  13C NMR; c)  31P NMR. 
 
Upon complexation, the FT-IR of MC1 depicted the νP=O stretch at 1120 cm-1. The NMR spectrum of 
MC1 showed relatively undefined peaks compared to ML1. The 1H NMR spectra showed the methylene 
protons (d in Reaction Scheme 3.4) shifted downfield to 3.79 ppm and the 31P NMR show a multiplet in the 
range of 8.23 – 8.10 ppm. These results could not unambiguously confirm the successful synthesis of MC1, 
but suggests that there was a mixture of products, most likely a mixture of ML1 and MC1. Thus, MC1 was 
 
ML1(H) 
ML1(C) 
ML1(P) 
f 
d 
c 
c d 
b a 
e 
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subjected to elemental analysis and the experimental values obtained (N, 5.73; C, 18.82; H, 5.27 %) 
corresponded to the calculated value for C5H13NO6P2GaCl (N, 4.00; C, 17.14; H, 3.74 %) with the inclusion 
of 2 molecules of ML1 and 6 molecules water. The ESI MS(-) spectra of MC1 showed a base peak at 246 m/z 
which corresponds to the molecular ion of ML1 without a hydrogen [M - H]-.  
3.4.3 Synthesis and characterization of DAB-PPI ligand (L2) 
Commercially available G1 PPI dendrimer was also modified with phosphonic acid to produce the 
dendritic derivative phosphonic acid modified G1 PPI dendrimer, L2. Once completed, the yellow reaction 
mixture was transferred to cold ethanol upon which a white precipitate formed. The precipitate was isolated 
under nitrogen and freeze dried to obtain L2 as a sticky yellow solid (76 % yield).  
 
 
Reaction Scheme 3.5: Synthesis of L2. 
 
In the FT-IR spectra (Table 3.1) of L2, the absorption observed at 1150 cm-1 represents the νP=O stretch 
and the νP-O-H stretch are observed at 902 and 1041 cm-1. The νP-O-H absorption band appears at 3313 cm-1 and 
the νP(O)-OH absorption can be observed at 1633 cm-1. Further characterization via 1H NMR, provided proof of 
the methylene protons (f) resonating as a doublet at 3.59 ppm with characteristic 2JH-P = 13 Hz coupling as 
well as the phenolic hydrogens (g) resonating in the range of 6.3 – 7.4 ppm. The resonances of the rest of the 
molecule were broad undefined peaks, which can be expected for these dendritic ligands as each dendrimer 
arm may reside in a slightly different environment. Another explanation could be that there is a mixture of 
products obtained. The mixture most likely comprises of mono- bi, and tri substituted analogues as all the 
starting reagents are washed away during purification. The 13C NMR spectra showed the carbons a and d 
(Reaction Scheme 3.5) in the expected region of 15 – 30 ppm, however they seem to appear in duplicate which 
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supports the assumption that it was a mixture of products. 31P NMR spectra display several peaks in the range 
of 7.5 – 8.0 ppm, which again suggests that the reaction yielded a mixture of products.  
In summary, for the phosphonic acid chelators, the FT-IR analysis always yielded broad undefined 
spectra, due to the hygroscopic nature of the products, thus only preliminary results were obtained. The FT-IR 
spectra of the ligands (Table 3.1) present absorption bands corresponding to νP=O, νP-O-H, and νP-O-H of the 
phosphonic acid moiety in the range 1200 – 1100 cm-1, 900 and 1050 cm-1, and 3400 – 3200 cm-1, respectively. 
Table 3.1: FT-IR of Phosphonic acid chelators. 
Compound  
 νC=O   νN-H  νP=O  νP-O-H  νP-O-H  νP(O)-OH 
 (cm-1)  (cm-1)  (cm-1)  (cm-1)  (cm-1)  (cm-1) 
ML1      1133  935   3384  1602 
MC1      1120  946   3363  1618 
ML2  1711    1142  912 985  3354  1638 
L1  1720  3236  1168  918 1034  3354  1651 
C1  1719  3387  1201   1007  3554  1639 
L2      1150  902 1041  3313  1633 
aRecorded as neat spectra on a ZnSe crystal, employing an ATR accessory. 
   
The 1H NMR spectrum obtained for ML2, L1, C1 and L2 could only provide tentative analysis of the 
compounds. In all spectra, there were resonances observed in the range of 3.5-3.7 ppm and 6 -8 ppm which 
correspond to the methylene (CH2-P) and acidic hydrogens (P-OH), respectively. The two separate hydrogens 
are represented as a doublet, exhibiting the common 2JH-P = 12 – 15 Hz coupling. The 13C NMR spectra display 
broad overlapping peaks in the region 50 – 55 ppm for 1JC-P coupling. For ML2, L1, and C1 there appeared 
several peaks in the carbonyl region (170 – 180 ppm) that provide more proof that some hydrolysis occurs 
during the reactions, yielding a mixture of products with several different carbonyl containing moieties (Figure 
3.13). It was possible to isolate the Ga (III) complex derivative of L1, which showed satisfactory elemental 
analysis and mass spectrometry result. 
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3.4.4 Synthesis of salicylaldimine modified Cyclam core PAMAM dendrimers 
The challenges encountered during the synthesis and isolation of the phosphonic acid derivatives were 
the impetus for the following section. As an alternative to the phosphonic acid ligands, the Schiff base 
condensation reaction with salicylaldehyde was employed to obtain the peripherally modified salicylaldimine 
dendrimer (L3). The first synthesis of a Schiff base was reported by Hugo Schiff in 186432 and ever since there 
has been a great interest in these compounds. The simple condensation of aldehydes or ketones with primary 
amines leads to a compound with a carbon nitrogen double bond, commonly referred to as an imine. The 
reaction produces water and usually requires dehydrating agents or the use of a Dean Stark apparatus to remove 
the water and drive the reaction towards completion. The Schiff bases can decompose during purification via 
silica gel chromatography as the imine is susceptible to hydrolysis, thus the best purification of these ligands 
is achieved via recrystallization. Schiff bases can coordinate to several metals and stabilize these in various 
oxidation states. In addition, they offer the possibility of incorporating chirality and have known biological 
applications.33, 34 
The synthesis of Schiff base derivative L3 (0.903 g, 44 % yield) was achieved by the condensation reaction 
between salicylaldehyde and D2. The dendritic Schiff base ligand was used as a multinuclear scaffold for the 
preparation of gallium and copper metal complexes. Following a literature procedure35, C4a was synthesized 
by adding GaCl3 in a 2:1 mol ratio (M: L) in an attempt to isolate the dinuclear species C4a (0.141 g, 71 % 
yield). The quadrupole nuclear species C4b (0.169 g, 89 % yield) was prepared according to a literature 
procedure36 where Ga(acac)3 was used in a 1: 5 ratio (M: L). Finally, a copper derivative C5 (0.179 g, 92 % 
yield) was prepared following a modified literature procedure37 in the hope of isolating the trinuclear complex 
where a copper metal is situated in the cyclam core. Where possible, the ligand and its corresponding 
complexes (Scheme 3.6) were characterized by FT-IR, 1H NMR, 13C NMR, elemental analysis and ESI-MS. 
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Scheme 3.6: Synthesis of L3, C4a, C4b and C5. 
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3.4.4.1 Infrared Spectroscopy and UV-Vis  
The FT-IR spectra (Figure 3.15) of the ligand L3 and the corresponding metal complexes C4a, C4b and 
C5 are summarized in Table 3.2. The absorption band at 1629 cm-1 corresponds to νC=N of the ligand and during 
all the subsequent complexation reactions a shift to lower wavenumbers for the imine absorption was observed. 
This can be justified by the stabilization of the nitrogen lone pair by the N-Metal bond, which causes a decrease 
in the bond order of C=N. Further absorptions worth monitoring is the band relating to νC-O, which can be seen 
as a sharp medium band appearing at 1279 cm-1 in the ligand. The band showed a decrease in intensity and a 
shift to higher wavenumbers for all the complexation reactions. Generally, the O-Metal bond formation causes 
νC-O to shift to higher wavenumbers. These observations, coupled with the disappearance of the phenolic O-H 
stretch present at 3297.02 cm-1 for the ligand, suggests that successful complexation between the N,O donor 
ligands and metal has occurred.38   
 
Figure 3.15: FT-IR of (a) L3; (b) C4a; (c) C4b; (d) C5. 
The UV-Vis spectrum of the ligand L3 as well as the complexes C4a, C4b and C5 is shown in Figure 
3.16. The ligand L3 shows a total of 4 absorption bands and the bands at 225 and 260 nm are associated with 
the π-π* transition of the aromatic rings. The band at 335 nm can be attributed to the n-π* transitions of the 
imine group.39 The dinuclear gallium complex C4a displays a total of 5 absorption bands. Both the aromatic 
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π-π* transition bands present in the ligand can be seen for C4a; however, the low wavenumber band at 225 
nm was unresolved with a shoulder at 280 nm. The shoulder at 280 nm coupled with the shift of the imine n-
π* transition to 324 nm suggests that the imine as well as the aromatic environments are altered during 
complexation, which would support the successful complexation of gallium through the salicylaldimine 
moiety.40 The gallium complex C4b displays a total of 3 bands, both the aromatic π-π* transition bands 
remained virtually unchanged relative to the ligand L3. The imine n-π* transition has shifted slightly to 323 
nm and the unknown band at 377 nm present in the spectrum of L3 has disappeared. The trinuclear copper 
complex C5 displays a total of 5 bands. The aromatic π-π* transition bands display two peaks at 224 and 235 
nm correlating to the corresponding absorption at 216 nm for L3. The shoulder at 299 nm and the shift in imine 
n-π* transition to 270 nm indicate complexation of Cu (II) and the salicyldimine moiety of L3. No d-d 
transitions are possible for C4a and C4b, because Ga (III) has no available d orbitals. It is expected to observe 
d-d transitions for C5 due to the d9 configuration of Cu (II); however, none was observed due to the low 
intensity.  
 
Figure 3.16: UV-Vis of L3 and C4a, C4b and C5. 
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Table 3.2: FT-IR and UV-Vis of L3, C4a, C4b and C5 
Compound 
 FT-IR (cm-1)  UV-Vis (nm) 
 C=N  C-O  π-π*  n-π* 
L3  1629  1280  216  256  328 
C4a  1621  1304    255  324 
C4b  1624  1314  210  256  323 
C5  1620  1321  224 and 235  270  350 
aRecorded as neat spectra on a ZnSe crystal, employing an ATR accessory. 
 
3.4.4.2 Nuclear Magnetic Resonance 
The ligand L3 was further characterized by 1H NMR and 13C NMR. In the 1H NMR spectrum the 
resonance at 8.30 ppm corresponds to the imine and integrates to 4 protons. A broad singlet can also be 
observed at 13.23 ppm indicative of the phenolic protons. The aliphatic proton h, represented in Figure 3.17, 
resonances were observed at 2.75 ppm for D2, which subsequently shifted downfield to 3.70 ppm in L3. The 
formation of an imine bond stabilizes the electron pair on the nitrogen by delocalization over the aromatic ring. 
Thus, the de-shielded protons h is seen downfield. The 13C NMR spectrum shows the imine carbon, aromatic 
carbons and the carbonyl carbon at 161.14, 166.59 and 172.86 ppm respectively. The same observation with 
regards to carbon h can be seen by the downfield shift from 41.66 ppm to 58.79 ppm from D2 to L3. 
 
Figure 3.17: Numbering corresponding to D2 and L3. 
The complex C4a and C4b was not soluble in CDCl3, thus no direct comparison could be made relative 
to L3. The NMR analysis attempted in D2O was inconclusive. Complex C5 was unsuitable for NMR analysis 
due to the paramagnetic nature of Cu. 
3.4.4.3 ESI-MS and EA 
ESI-MS is also useful to analyse metal chelation/ complex formation. The prominent fragments observed 
in ESI-MS spectra of C4b are highlighted in Figure 3.18. The base peak at 358 m/z can be assigned to the 
quadrupole pseudo molecular ion potassium ([M +3H + K]4+) adduct of the parent ion (1488 m/z).  
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Figure 3.18: ESI MS of C4b. 
 
A plausible fragmentation pathway (Figure 3.19) shows the parent ion (I) undergoing sequential loss of 
a complete dendrimer branch unit (X) represented by the peaks at 1073, 855, 837 m/z peaks correlating to II, 
III, IV, respectively. These values correlate well with the calculated values 1165, 842, 519 m/z, respectively. 
A possible explanation for the differences can be attributed to all the possible protonation sites present in the 
dendritic molecule. Additionally, the peak at 323 m/z correlates exactly with the calculated value of a missing 
branch. Further characterization of C4b by elemental analysis corresponded well with the calculated values 
although the results suggest the inclusion of water molecules within the dendrimer architecture.  
The positive mode ESI-MS spectrum of C5 display the molecular ion [M]+ at 1258.40 m/z, which 
correlates to the ligand and three Cu (II) centers. The sequential loss of copper ions from the molecule could 
be observed by the m/z ratios at 1258.40, 1196.47 and 1134.56. The base peak observed at 399 m/z can be 
assigned to the triply-charged pseudo molecular ion with the loss of a copper center [M - Cu]3+. The doubly-
charged pseudo molecular ion [M - Cu]2+ is also observed at 598 m/z. Additionally, the peak at 219 m/z 
correlates with the cyclam sodium adduct. The elemental analysis of C5 correlates to the calculated value; 
however, there was once again an indication of water molecules present. 
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Figure 3.19: Plausible fragmentation pathway for C4b. 
 
 
Figure 3.20: ESI MS of C5. 
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3.5 Conclusion 
The first section of the chapter deals with the synthesis and characterization of phosphonic acid 
derivatives via the Irani-Moedritzer reaction and the corresponding gallium complexes. The synthesis of 
phosphonic acid modified cyclam-cored PAMAM dendrimers (L1) was attempted. Several different routes to 
isolate the product were attempted and were unsuccessful. Thus, the gallium complex of L1 was synthesized 
in an attempt to isolate C1. During the synthesis of the model ligand (ML2), which represented the dendritic 
wedge of L1, it was suspected that the amide was susceptible to hydrolysis under the reaction conditions 
employed. The model ligand (ML1), which represented the peripheral chelator of L1, was successfully isolated 
employing the Irani-Moedritzer reaction as was the corresponding gallium complex, MC1. The synthesis of 
the dendritic analogue, L2, indicated that the phosphorylation of the amine functionalities had occurred, 
however, a mixture of mono-, di- and tri- substituted products were present in the reaction mixture. 
The spectroscopic characterization of these phosphonic acid analogues was complicated due to the 
hygroscopic nature of the products. The FT-IR analysis always yielded broad undefined spectra and NMR 
results indicated a mixture of products present, thus only preliminary results were obtained. The use of 
dendrimers as scaffolds for these multi nuclear imaging modalities should be approached differently. An option 
would be to synthesize dendrons and modify these before coupling it to a core to form the dendrimer. This 
would simplify the purification of the dendrons and give more reassurance of the products synthesized. 
Lastly, the Schiff base ligand (L3) was chosen as an alternative ligand based on their simplistic synthesis 
and range of coordination chemistry. The corresponding multinuclear complexes (C4a, C4b and C5) using the 
appropriate gallium and copper salts were all successfully synthesized and characterized. 
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3.6 Experimental Section  
Solvents were obtained from Merck or Kimix and dried by distilling over the appropriate drying agents. 
Toluene was dried by distillation over sodium/benzophenone. Methanol was dried by distillation over 
magnesium turnings and iodine while dichloromethane was dried over phosphorus pentoxide. All reagents 
were purchased from either Sigma Aldrich or Merck and was used without any further purification.  
All Infrared spectra were recorded on a Thermo Nicolet Avatar 330 FT-IR spectrometer with a Smart 
Performer (Zn/Se) ATR attachment. 1H and 13C nuclear magnetic resonance spectra were recorded using a 300 
MHz Varian VNMRS, 400 MHz Varian Unity Inova or 600 MHz Varian Unity Inova NMR instrument using 
deuterated solvents. Chemical shifts (δ) were recorded using the residual solvent peak or external reference 
(TMS). All chemical shifts are reported in parts per million and all spectra were obtained at 25 °C. Samples 
for EA analysis were done on a Perkin-Elmer 2400 Series II CHNS/O Elemental Analyzer at the University of 
Kwa-Zulu Natal. Mass spectra were recorded on a Waters Synapt G2 spectrometer. 
 
3.6.1 Synthesis of phosphonic acid modified cyclam-cored PAMAM (L1) 
Solid phosphorous acid (1.0860 g, 13.244 mmol) was dissolved in 37 % hydrochloric acid (3.3 ml, 37 
mmol) and refluxed at 80 °C under nitrogen before adding 37 % formaldehyde solution (1.1296 g, 15.968 
mmol) dropwise. Thereafter the solution temperature was raised to 90 °C before adding D2 (0.587 g, 0.880 
mmol) dissolved in distilled water (6 ml) dropwise. After complete addition, the reaction mixture was allowed 
to reflux for an additional hour. The solvent of the yellow reaction mixture was removed via rotary evaporator 
to afford a yellow oil. The yellow residue was dissolved in a minimum amount of water and transferred to hot 
methanol upon which a white precipitate formed. The white precipitate (1.074 g) was filtered under nitrogen 
and rinsed with Et2O before drying under vacuo. IR (cm-1) ʋ(C=O) = 1720 cm-1, ʋ(P=O) = 1168 cm-1, 𝜈sym(P-
O-H) = 918 cm-1, 𝜈asym(P-O-H) = 1034 cm-1, 𝜈(P-O-H) = 3354 cm-1, 𝜈(P(O)-OH) = 1651 cm-1. 1H NMR (300 
MHz, D2O) δ 7.95 (s, P-OH), 5.77 (s, P-OH), 4.00 – 1.00 (m. extensive overlapping), 3.58 (m, N-CH2-CH2-
C(O)-NH, -C(O)-NH-CH2-CH2-N), 3.37 (d, 2JP,H = 14 Hz, N-CH2-P), 3.18 (m, N-CH2-CH2-C(O)-NH, -C(O)-
NH-CH2-CH2-N), 1.29 (m, N-CH2-CH2-CH2-N). 13C {1H} NMR (101 MHz, D2O) δ 174.6 (s, C=O), 173.9 (s, 
C=O), 173.3 (s, C=O), 55 – 30 (multiple peaks), 49.4 (s, N-CH2-P). 31P {1H} NMR (162 MHz, D2O) δ 19.9 
(s), 9.33 (s), 8.8 (s, N-CH2-P), 8.5 (s), 8.0 (s), 7.6 (s), 7.4 (d, J = 31.7 Hz), 7.2 (s, N-CH2-P), 6.9 (s), 3.6 (s, 
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PO3H3), 0.6 (s). Elemental analysis Calculated: N, 9.42; C, 28.26; H, 5.65% Experimental: N, 11.327; C, 
25.445; H, 7.094%. ESI(+) MS: [C42H94N12O28P8]3+ = 489.29 m/z, [C42H94N12O28P8 + Na]3+ = 511.25 m/z (base 
peak), [C42H94N12O28P8  + 2Na]3+ = 533.21 m/z. ESI(-) MS: [C8H20N2O10P3 + K - H]- = 434.99 m/z, 
[C8H18N2O7P2 + K - H]- = 355.02 m/z. 
3.6.2 Synthesis of Gallium (III) phosphonic acid modified cyclam-cored PAMAM (C1) 
L1 (0.3036 g, 0.1704 mmol) was suspended in warm ethanol (20 ml). A suspension of GaCl3 (0.5388 g, 
3.060 mmol) in ethanol (5 ml) was added, before stirring the solution at reflux for 24 hours. The warm reaction 
mixture was slowly added to a beaker charged with 100 ml cold diethyl ether upon which a white precipitate 
crashed out of solution. The precipitate was isolated via filtration under nitrogen, before drying under reduced 
pressure overnight. C1 (0.234 g, 57 % yield) IR (cm-1) ʋ(C=O) = 1719 cm-1, ʋ(P=O) = 1201 cm-1, 𝜈(P-O-H) = 
1007 cm-1, 𝜈(P-O-H) = 3554 cm-1, 𝜈(P(O)-OH) = 1639 cm-1. 1H NMR (600 MHz, D2O) δ 7.40 (s, P-OH), 6.33 
(s, P-OH), 4.00 – 1.00 (m. extensive overlapping), 3.62 (d, 2JP,H = 12.3 Hz, N-CH2-P), 1.30 (m, N-CH2-CH2-
CH2-N). 31P NMR {1H} (121 MHz, D2O) δ 17.9 (s), 10.0 – 7.0 (m, N-CH2-P), 4.4 (s, PO3H3). Elemental 
analysis: Found: C: 21.003 %, N: 7.179 %, H: 5.379 %; Calculated: C: 20.98 %; N: 6.99 %; H: 3.69 %. ESI(+) 
MS: [C3H7NO6P2GaCl + K]+ = 357.04 m/z. 
 
3.6.3 Synthesis of Model Ligand 2 
3.6.3.1 Synthesis of dimethyl 3,3'-(propylazanediyl)dipropanoate (ML2a) 
Propyl amine (1.048 g, 17.73 mmol) was dissolved in MeOH (3 ml) before adding methyl acrylate (16 
ml, 177 mmol). The reaction mixture was placed in the microwave reactor for 90 minutes at 40 °C with 50 W 
radiation. The reaction mixture was cooled to room temperature, before repeating the microwave reaction as 
mentioned above. The solvent was removed to afford a yellow oil. The oil was purified via silica gel 
chromatography using the eluent DCM: MEOH (9:1) to afford a light yellow oil (3.049 g, 74 % yield). IR (cm-
1) ʋ(C=O) = 1732 cm-1. ʋ(C-N) = 1435 cm-1. 1H NMR (600 MHz, CDCl3) δ 3.63 (s, 6H, -C(O)OCH3), 2.73 (t, 
3JH-H = 7.2 Hz, 4H, -N-(CH2-CH2-C(O)OMe)2), 2.41 (t, 
3JH-H = 7.2 Hz, 4H, -N-(CH2-CH2-C(O)OMe)2), 2.35 
– 2.33 (m, 2H, CH3-CH2-CH2-N), 1.44 – 1.37 (m, 2H, CH3-CH2-CH2-N), 0.81 (t, 
3JH-H = 7.4 Hz, 3H, -CH3). 
13C NMR {1H} (151 MHz, CDCl3) δ 172.9 (s, C=O), 55.7 (s, CH3-CH2-CH2-N), 51.5 (s-N-(CH2-CH2-
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C(O)OMe)2), 49.2 (s, -C(O)OCH3), 32.4 (s, -N-(CH2-CH2-C(O)OMe)2), 20.1 (s, CH3-CH2-CH2-N), 11.6 (s, 
CH3-CH2-CH2-N). 
3.6.3.2 Synthesis of 3,3'-(propylazanediyl)bis(N-(2-aminoethyl)propanamide) (ML2b) 
Ethylenediamine (88 ml, 131 mmol) dissolved in EtOH (100 ml) was added to a stirring solution of 
dimethyl 3,3'-(propylazanediyl)dipropanoate (3.049 g, 13.18 mmol) dissolved in EtOH (20 ml). The reaction 
mixture was stirred in the dark at room temperature for 5 days. The solvent and excess ethylenediamine was 
removed via rotary evaporizer to obtain ML2b as a yellow oil (3.012 g, 79 % yield). IR (cm-1) ʋ(C=O) = 1636 
cm-1. ʋ(C-N) = 1456 cm-1, ʋ(N-Hstretch) = 3283 cm-1 and ʋ(N-Hbend) = 1544 cm-1. 1H NMR (400 MHz, D2O) δ 
3.24 (t, J = 6.3 Hz, 4H, -N-(CH2-CH2-C(O)-NH-CH2-CH2-NH2)2)), 2.80 (t, J = 7.4 Hz, 4H, -N-(CH2-CH2-
C(O)-NH-CH2-CH2-NH2)2)), 2.72 (t, J = 6.3 Hz, 4H, -N-(CH2-CH2-C(O)-NH-CH2-CH2-NH2)2)), 2.69 (s, 3H, 
EDA), 2.44 (m, 4H, -N-(CH2-CH2-C(O)-N-CH2-CH2-NH2)2), 2.43 – 2.41 (m, 2H, CH3-CH2-CH2-N), 1.52 – 
1.42 (m, 2H, CH3-CH2-CH2-N), 0.87 (t, 
3JH-H = 7.4 Hz, 3H, -CH3). 13C NMR {1H} (151 MHz, CDCl3) δ 172.8 
(s, C=O), 55.5 (s, CH3-CH2-CH2-N), 50.0 (s N-(CH2-CH2-C(O)NH)2), 46.4 (s), 45.6 (s), 44.8 (s), 44.0 (s), 43.5 
(s), 42.8 – 41.8 (m, C(O)NH-CH2-CH2-NH2), 41.6 (s), 41.4 (s, C(O)NH-CH2-CH2-NH2), 40.2 (s), 39.3 (s), 
35.7 (s), 33.9 (m, -N-(CH2-CH2-C(O)NH)2), 33.6 (s), 32.5 (s), 23.0 (s), 19.8 (s, CH3-CH2-CH2-N), 11.9 (s, 
CH3-CH2-CH2-N). 
3.6.3.3 Synthesis of ML2 
3,3'-(propylazanediyl)bis(N-(2-aminoethyl)propanamide) ML2b (0.185 g, 0.641 mmol) was dissolved in 
ethanol (1 ml), before adding phosphorous acid (0.642 g, 7.83 mmol) and 37 % HCl (0.90 ml) to the light 
yellow solution. The reaction mixture was stirred at room temperature for 1 hour before adding 35 % 
formaldehyde (1.0 ml). The reaction mixture was left to stir overnight before raising the temperature to 100 
°C for 8 hours. Thereafter the solvent was removed via the rotary evaporizer (60 °C) to obtain a golden oil. 
The oil was dissolved in warm ethanol before adding the solution to cold diethyl ether. A white precipitate 
immediately crashed out of solution. The precipitate was isolated via filtration under a nitrogen blanket; 
however due to its hygroscopic nature, the precipitate quickly became a sticky yellow viscous solid. (0.421 g, 
77 % yield) IR (cm-1) ʋ(C=O) = 1711 cm-1, ʋ(P=O) = 1142 cm-1, 𝜈sym(P-O-H) = 912 cm-1, 𝜈asym(P-O-H) = 985 
cm-1, 𝜈(P-O-H) = 3354 cm-1, 𝜈(P(O)-OH) = 1638 cm-1. 1H NMR (400 MHz, D2O) δ 7.64 (s, P-OH), 6.04 (s, 
P-OH) 3.95 (d, J = 21.4 Hz), 3.91 – 3.49 (m,N-CH2-P), 3.49 – 3.15 (m), 3.26 (d, J = 4.2 Hz), 3.26 (d, J = 4.2 
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Hz), 3.09 (s, possibly C=O), 2.80 (d, J = 4.6 Hz), 1.78 (m, CH3-CH2-CH2-N) 1.17 (t, J = 7.1 Hz, CH3-CH2-
CH2-N), 0.97 (t, J = 7.4 Hz, CH3-CH2-CH2-N).  
3.6.4 Synthesis of ((propylazanediyl)bis(methylene))diphosphonic acid (ML1) 
Phosphorous acid dissolved in distilled water (10 ml) was added to a stirring solution of 37 % hydrochloric 
acid (5 ml, 60 mmol) while maintaining the temperature below 40 °C. Propyl amine (0.7234 g, 12.24 mmol) 
was dissolved in distilled water (10 ml), before adding the yellow solution dropwise over an hour to the 
HCl/PO3H3 solution. Upon complete addition, the solution temperature was raised to 85 °C before adding 35 
% paraformaldehyde solution (4.5 ml, 60 mmol) dropwise. The reaction mixture was refluxed (105 °C) an 
additional hour. The solvent was removed to afford a clear oil. The oil was dissolved in methanol and layered 
with diethyl ether before placing the solution in the freezer overnight. The resulting white precipitate was 
separated via filtration and dried under high vacuo for 24 h before isolating ML1 (2.412 g, 80 % yield). IR 
(cm-1) ʋ(P=O) = 1133 cm-1, 𝜈(P-O-H) = 935 cm-1, 𝜈(P-O-H) = 3384 cm-1, 𝜈(P(O)-OH) = 1602 cm-1. 1H NMR 
(600 MHz, D2O) δ 7.32 (s, P-OH), 6.20 (s, P-OH), 3.45 (d, 
2JH,P = 12.8 Hz, 4H, -N-(CH2-PO3H2)2), 3.34 – 
3.31 (m, 2H, CH3-CH2-CH2-N), 1.69 – 1.63 (m, 2H, CH3-CH2-CH2-), 0.84 (t, 
3JH-H = 7.4 Hz, 3H, CH3-CH2). 
13C NMR {1H} (101 MHz, D2O) δ 59.0 (t, 
3JC-P = 3.8 Hz, -CH2-N-(CH2-PO3H2)2), 51.6 (d, 
1JC,P = 137.8 Hz, -N-CH2-PO3H2), 17.4 (s, CH3-CH2-CH2-N), 10.4 (s, CH3-CH2-CH2-N). 31P NMR (162 MHz, 
d2o) δ 23.2 (s), 8.8 (s, -N-(CH2-PO3H2)2)), 5.4 (s, PO3H3), 5.1 (t, 
1JP-H = 102.8 Hz, -N-(CH2-PO3H2)2)). 
Elemental analysis Calculated: N, 7.29; C, 22.63; H, 6.64 % Experimental: N, 5.67; C, 24.30 and H, 6.12 %. 
ESI(-) MS: [M - H]- = 246 m/z. 
3.6.5 Synthesis of gallium ((propylazanediyl)bis(methylene))bis(hydrogen phosphonate) chloride 
(MC1) 
Solid GaCl3 (3.0911 g, 17.565 mmol) was dissolved in 5 ml dry methanol. ML1 (0.955 g, 3.86 mmol) 
was suspended in 15 ml dry methanol before adding of 3.51 M GaCl3 solution (0.95 ml, 3.3 mmol) to the 
suspension. Upon addition, the milky white solution immediately became clear pink, gradually changing to 
purple after 1 hour. The reaction mixture was allowed to stir an additional 12 hours, during which the solution 
became milky white. The solvent was removed via rotary vaporizer. The residue was dissolved in a minimum 
amount of toluene and layered with diethyl ether. After 1 day, the white precipitate (1.0255 g, 75 % yield) was 
isolated via filtration. m.p. > 250 °C, IR (cm-1) ʋ(P=O) = 1120 cm-1, 𝜈(P-O-H) = 946 cm-1, 𝜈(P-O-H) = 3363 
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cm-1, 𝜈(P(O)-OH) = 1618 cm-1. 1H NMR (400 MHz, D2O) δ 7.66 (s, P-OH), 6.06 (s, P-OH), 3.79 (d, J = 7.31 
Hz) 3.75 – 3.10 (m),3.01 (s), 1.86 – 1.72 (m, CH3-CH2-CH2-N), 1.01 – 0.96 (m, CH3-CH2-CH2-N). 13C NMR  
(101 MHz, D2O) δ 54.4 (s), 10.5 (dd, J = 3.6, 2.3 Hz). 31P NMR (162 MHz, d2o) δ 21.3 (s), 9.8 (s), 8.2 – 8.1 
(m, -N-(CH2-PO3H2)2)), 4.3 - 3.8 (m, PO3H3). Elemental analysis Calculated: N, 4.00; C, 17.14; H, 3.74 % 
Experimental: N, 5.73; C, 18.82; H, 5.27 %. ESI(-) MS: [M - 2H + MeOH]2- = 190 m/z. 
3.6.6 Synthesis of L2 
G1 DAB-PPI (0.682 g, 2.15 mmol) dissolved in distilled water (5 ml) before adding phosphorous acid 
(2.827 g, 34.47 mmol) and 37 % HCl (4.3 ml, 51 mmol) to the solution whilst ensuring the temperature stayed 
below 40 °C. Thereafter 37 % formaldehyde (3.4 ml, 43 mmol) was added dropwise before the reaction 
temperature was raised to 100 °C. After the reaction mixture was stirred for 4 hours the warm solution was 
immediately added to cold EtOH (200 ml) upon which a precipitate formed. The precipitate (1.748 g) was 
washed with diethyl ether, taken up in water and freeze dried before analysis. IR (cm-1) 𝜈(P=O) = 1150 cm-1, 
𝜈sym(P-O-H) = 902 cm-1, 𝜈asym(P-O-H) = 1041 cm-1, 𝜈(P-O-H) = 3313 cm-1, 𝜈(P(O)-OH) = 1633 cm-1. 1H NMR 
(600 MHz, D2O) δ 7.42 (s, P-OH), 3.62 (s, P-OH), 3.78 (d, J = 12.9 Hz, -N-CH2-PO3H2), 3.59 (d, J = 12.6 
Hz, -N-CH2-PO3H2), 3.35 – 3.31 (m), 3.06 – 3.03 (m), 2.98 – 2.90 (m), 2.31 (m, N-CH2-CH2-CH2-CH2-N), 
1.86 (m, N-CH2-CH2-CH2-CH2-N). 13C NMR {1H} (75 MHz, D2O) δ 58.0 (s), 53.5 – 49.5 (m), 37.0 (s), 22.2 
(s), 21.1 (s), 19.0 (s), 17.4 (s). 31P NMR {1H} (162 MHz, D2O) δ 21.9 (s), 9.5 – 9.3 (m), 8.0 – 7.4 (m, -N-CH2-
PO3H2), 4.1 (s, PO3H3), 0.6 (s). 
3.6.7 Synthesis of L3 
G1.0 Cyclam core PAMAM (1.250 g, 1.900 mmol) was dissolved in ethanol (20 ml) before adding 
salicylaldehyde (1.62 ml, 15,2 mmol) and stirring the solution at room temperature for 3 days. A yellow 
precipitate was observed after 1 day. After 3 days the reaction flask was placed in the freezer for an hour before 
isolating the yellow precipitate via filtration. The precipitate was rinsed with cold methanol (3 portions of 20 
ml). The solvent of the filtrate was reduced and the concentrated solution placed in the freezer overnight. The 
resulting yellow precipitate was filtered. The combined precipitate (0.903 g, 44 % yield) was dried under 
reduced pressure overnight. IR (cm-1) 𝜈(N-H) = 3297 cm-1, 𝜈(C=O) = 1629 cm-1. 1H NMR (600 MHz, CDCl3) 
δ 13.2 (s, OH), 8.30 (s, 4H, HC=N), 7.39 – 7.26 (dt, 3JH-H = 7.7 Hz, 
4JH-H 1.7 Hz= , 4H, Ar-H), 7.21 (dd, 
3JH-H 
= 7.7Hz, 4JH-H = 1.6 Hz, 4H, Ar-H), 6.89 (d, 
3JH-H = 8.2 Hz, 4H, Ar-H), 6.86 (t, 
3JH-H = 7.5 Hz, 4H, Ar-H), 3.70 
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(t, J = 5.6 Hz, 8H, -C(O)-NH-CH2-CH2-N=), 3.52 (dd, J = 11.5, 5.8 Hz, H, -C(O)-NH-CH2-CH2-N=), 2.52 (t, 
8H, -N-CH2-CH2-C(O)NH-), 2.34 (s, 8H, -N-CH2-CH2-N-), 2.24 (tt, 16H, -N-CH2-CH2-CH2-N- and -N-CH2-
CH2-C(O)NH-), 1.35 (s, 4H, -N-CH2-CH2-CH2-N-). 13C NMR {1H} (151 MHz, CDCl3) δ 172.8 (s, -C(O)NH-
), 166.5 (s, Ar-OH), 161.1 (s, -CH=N-), 132.6 (s, Ar), 31.6 (s, Ar), 118.9 (s, Ar), 118.7 (s, Ar), 117.1 (s, Ar), 
58.7 (s, -C(O)-NH-CH2-CH2-N=), 51.1 (s, -N-CH2-CH2-C(O)NH-), 50.6 (s, -N-CH2-CH2-CH2-N-), 49.3 (s, -
N-CH2-CH2-N-), 40.1 (s, -C(O)-NH-CH2-CH2-N=), 33.1 (s, -N-CH2-CH2-C(O)NH-), 22.6 (s, -N-CH2-CH2-
CH2-N-). 
3.6.8 Synthesis of C4a 
GaCl3 (0.571 g, 0.328 mmol) was dissolved in dry methanol (5 ml) and added to a stirring solution of L3 
(0.176 g, 0.164 mmol) and Et3N in dry methanol (30 ml). The reaction mixture was stirred for 1 hour before 
adding excess sodium perchlorate. After 24 hours, the yellow precipitate was isolated via filtration and dried 
under reduced pressure. (C4a, 0.141 g, 71.21 % yield). IR (cm-1) 𝜈(C=N) = 1621 cm-1, 𝜈(C-O) = 1304 cm-1. 
UV-Vis (nm) π-π* = 255 nm, n-π* = 324 nm. 
3.6.9 Synthesis of C4b 
Ga(acac)3 (0.6881 g, 1.773 mmol) was dissolved in dry ethanol (5 ml) and added dropwise to a stirring 
solution of L3 (0.1904 g, 0.1774 mmol) in dry ethanol (20 ml). The reaction mixture was stirred under inert 
conditions at reflux temperature for 3 hours. Thereafter, the solvent was removed and the obtained yellow 
precipitate was purified by dissolving it in a minimum amount of ethanol and layering the solution with diethyl 
ether before cooling the solution to 8 ° C for 24 hours. The resulting yellow precipitate was isolated via 
filtration and rinsed with dry diethyl ether before drying under reduced pressure. (C4b, 0.169 g, 88.95 % yield) 
IR (cm-1) 𝜈(C=N) = 1624 cm-1, 𝜈(C-O) = 1314 cm-1. UV-Vis (nm) π-π* = 210 and 256 nm, n-π* = 323 nm. 
ESI MS: [M + K]4+ = 358 m/z. 
3.6.10 Synthesis of C5 
Copper acetate (0.1716 g, 0.8601 mmol) was dissolved in dry ethanol (20 ml) and added dropwise to a 
stirring solution of L3 (0.1737 g, 0.1618 mmol) in dry ethanol (20 ml). The green reaction mixture was stirred 
under inert conditions at reflux temperature for 3 hours. Thereafter, the solvent was removed and the obtained 
green precipitate was recrystallized by cooling a concentrated solution 8 ° C for 24 hours. The resulting green 
precipitate was isolated via filtration and rinsed with dry diethyl ether before drying under reduced pressure. 
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(C5, 0.179 g, 92.27 % yield) IR (cm-1) 𝜈(C=N) = 1620 cm-1, 𝜈(C-O) = 1321 cm-1. UV-Vis (nm) π-π* = 224, 
235 and 270 nm, n-π* = 350 nm. ESI MS: [M]+ = 1197 m/z, [M - Cu]2+ = 598 m/z, [M - Cu]3+ = 399 m/z.  
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4 DNA BINDING STUDIES 
4.1 Introduction 
In this chapter, the focus shifts towards drug-DNA interaction, with a particular focus on dendrimers, 
ligands and complexes synthesized and discussed in preceding chapters. The aim was to establish whether 
the compounds interacted with DNA and if so, how and to what extent? The introduction looks at the DNA 
structure in relation to all the possible binding modes. These binding modes are categorized as covalent or 
non-covalent. Lastly, the preliminary assessment of the selected compounds by means of UV-Vis 
spectroscopy titration experiments is discussed.  
4.2 DNA Structure 
DNA has been known to be the cellular target for many cytotoxic anticancer agents. Targeting DNA 
allows for the regulation of cell functions by controlling transcription pathways or by interfering with 
replication. A quick look at the structure of DNA (Figure 4.1) indicates several possible modes of bonding. 
A single strand consists of DNA bases (Adenine, Cytosine, Guanine, Thymine) in four possible 
combinations which are connected to a backbone of deoxyribose sugars. These sugars are covalently linked 
through one or more phosphate groups at the 3’ and/or 5’ hydroxy group forming a phosphodiester linkage. 
The DNA bases interact through Watson-Crick hydrogen bonds, which gives the famous double helix 
structure.1 The DNA bases present sites where alkyl groups can be added, where drug molecules can bind 
covalently and even crosslink consecutive base pairs. The cavity in-between base pairs stabilize molecules 
via π-π stacking, the major and minor grooves stabilize drug molecules through van der Waals and/or 
hydrogen bonding while the phosphate backbone offers the opportunity for electrostatic interactions.  
4.3 Mode of DNA binding 
For the effective design of drug molecules, it is important to know the mode of DNA binding of the 
molecule under investigation. If the mode of binding can be associated with specific aspects present in the  
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Figure 4.1: General Structural features of DNA. 
molecule, one could tailor the molecule to exhibit the desired mode of binding. However, when 
incorporating these alterations, the overall solubility of the molecule should always be kept in mind. The 
molecule should ideally be soluble under physiological conditions. To this end an array of potential 
anticancer molecules needs to be studied to shed some light on any structure-activity relationship.2 
4.3.1 Covalent Binding 
Covalent bonding constitutes an important binding mode to transform DNA irreversibly, via alkylation 
or an inter-/intrastrand crosslink, therefore restricting proper cell growth. Since the discovery of cisplatin 1 
by Rosenburg et al.3  in the late 1960s, a paradigm shift in the design of anticancer drugs was observed. 
The square planar cisplatin complex binds covalently by forming interstrand crosslinks. Once liberated 
from its chloride ions, the platinum ion is known to form covalent interstrand crosslinks with N7 atoms of 
consecutive guanine bases4, which permanently alter the structure of DNA. Although cisplatin is effective, 
it reacts with all DNA non-selectively inducing severe side effects resulting in high cytotoxicity. In order 
to circumvent these disadvantages, the next generation platinum drugs, Carboplatin 2 and Oxaliplatin 3, 
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exploited the use of less labile dicarboxylate leaving groups leading to improved stability as well as 
enhanced solubility. Some of the second generation platinum based drugs are shown in Figure 4.2. 
 
Figure 4.2: Common covalent anticancer drugs (All IC50 values in µM): (1) cisplatin, (2) Carboplatin, (3) Oxaliplatin, (4 - 6) 
N,N,O-tridentate platinum complexes5 and  (7) G0-PAMAM– py4–[CuCl2]7 .6 
 
More recently a series of N,N,O-tridentate platinum complexes 4 - 6 (Figure 4.2) with both chloride 
and chelated carboxylate moieties as leaving groups was synthesized by Gou et al.5 They evaluated these 
complexes against several human tumor cell lines such as A549 (non-small cell lung cancer), HCT-116 
(colorectal cancer), MCF-7 (breast cancer) and HepG-2 (hepatocellular carcinoma). They found compound 
5 (Figure 4.2) to be almost two-fold more active than Oxaliplatin against HCT-116 and its activity against 
MCF-7 was comparable to cisplatin.5 From the literature, it is known that bulky adducts aids with distortion 
of the DNA backbone, which in turn affects transcription and replication of the DNA.7,8 To this end, the 
use of dendrimers as ligands has been investigated. Copper complexes incorporated into dendrimers were 
evaluated against MOLT-4 (leukemia cells), MCF-7 (breast cancer cells) and Chang Liver cells by Chu et 
al.6 Among other, the group studied G0-PAMAM– py4–[CuCl2]7 7 (Figure 4.2) which exhibited an IC50 
value of 10.2 ± 1.5 µM against MCF-7.  
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4.3.2 Non-Covalent Binding 
Molecules interacting non-covalently with DNA do so via reversible hydrophobic-, ionic-, hydrogen 
bonding, and/or Van der Waals interactions and cause conformational changes in the DNA, such as 
torsional tension for example. It interferes with protein-DNA interactions and can potentially lead to DNA 
strand breaks.9 The use of metal complexes as anticancer agents has been under investigation with only a 
few examples in clinical trials and even less are in actual use. By incorporating metal centers into drug-like 
molecules the structural, reactivity and optical properties of the molecule change considerably. The inherent 
properties (geometry, redox state, etc.) of the metal atom influence the magnetic, thermodynamic and 
kinetic behavior of the molecule.10 These physico-chemical changes can be monitored in order to deduce 
the manner in which the molecule interacts with DNA. Non-covalent interactions with DNA are categorized 
in three classes: intercalation, groove binding and electrostatic binding.  
4.3.2.1 Intercalation 
Molecules that interact with DNA via intercalation usually consist of planar heterocyclic moieties that 
can stack between adjacent DNA base pairs where the interactions are facilitated by π-π stacking. 
Intercalators interact with DNA independent of the nature of the DNA sequence and this occurs via van der 
Waals forces, hydrogen bonding, and/or hydrophobic affinity.11 Two modes of intercalation are known viz. 
classical and threading intercalation.  
An example of classical intercalators was studied by Uma et al.12 They synthesized a copper (II) 
complex [Cu(Itpy)2](ClO4)2 (Itpy = imidazole terpyridine) and determined the binding mode using calf 
thymus DNA (CT DNA). Analysis via spectroscopic titrations showed a decrease in intensity 
(hypochromism) of the intraligand transition at 336 nm upon addition of DNA, which is indicative of 
intercalation. If intercalation was the mode of binding, the DNA base pairs would have to separate in order 
to accommodate the ligand which would cause an overall increase in length of DNA which inevitably leads 
to an increase in viscosity of the DNA solution.13 The viscosity measurements indicated a steady increase 
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in the relative viscosity of the solution. Thermal denaturing experiments determine the temperature at which 
half the DNA double helix denatures to single strands and is regarded as the melting temperature (Tm).13 In 
the case of the copper complex monitored above an increase of ΔTm = 5.0 ± 0.5 °C was observed which 
indicated that the imidazole terpyridine ligand stabilized the DNA double helix. 
Sunita and co-workers14 studied the DNA-binding properties of mixed Cu (II) 2,6-bis(benzimidazol-
2-yl) pyridine complexes (9, 10) via absorption spectroscopy, fluorescence spectroscopy, viscosity 
measurements and thermal denaturation methods. Spectroscopic titrations indicated the complexes bind to 
DNA through intercalation. Absorption spectra of the complexes in the presence of CT DNA are shown in 
(Figure 4.3a) and these indicate hypochromism as well as bathochromism of the metal to ligand charge 
transfer (MLCT) band upon addition of CT DNA. This is due to the strong π-π stacking interaction between 
the aromatic chromophore and the base pairs of DNA. Emission spectra, shown in (Figure 4.3b), indicate 
an increase in intensity upon addition of CT DNA, which indicates that the complexes bind to the 
hydrophobic pockets inside the DNA. Additionally, emission spectra of CT DNA pretreated with ethidium 
bromide (a proven intercalators15) show a decrease in intensity upon addition of the complexes as they 
compete with ethidium bromide for DNA binding (Figure 4.3c).  Furthermore, thermal denaturing 
experiments indicated a 5 - 8 °C increase of Tm and viscosity measurements show a steady increase in 
relative viscosity as a result of increasing the concentration of 9 and 10.  
Threading intercalation is based on the same principle, but the molecules usually contain chains on 
opposite sides of the planar ring system which, once intercalated, allows the chains to interact with grooves 
in its close proximity. This mode of binding may hold several advantages concerning its biological activity, 
such as simultaneous blockade of both DNA grooves which may help effectively regulate gene expression, 
improved linker-DNA interactions, as well as lower dissociation rates from cellular DNA.16 Shahabadi et 
al.17 studied a copper complex (11) (Figure 4.4) containing 4,7-diphenyl-1,10-phenanthroline (DIP) as the  
Stellenbosch University  https://scholar.sun.ac.za
UV-Vis DNA Binding Studies 
   111 
 
 
Figure 4.3: Mixed Cu(II) 2,6-bis(benzimidazol-2-yl) pyridine complexes (9, 10)14 (a) UV-Vis spectroscopy titration experiments 
(b) Fluorescence spectroscopy titration experiments (c) Fluorescence spectroscopy competitive titration experiments. 
N,N-chelate in combination with (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione 
(Curcumin). DIP was chosen to impart intercalation as a possible binding mode, whereas Curcumin is a 
known groove binder.18 The intrinsic binding constant of 11 was found to be Kb = 2.50 ±0.2 × 105 M-1, 
which was markedly higher than comparative Cu(Cur)(H2O)Cl 12 (Kb = 5.21 × 104 M-1) and [Cu(Cur)2]  13 
(Kb = 1.73 × 104 M-1). The enhanced DNA binding is likely due to a synergistic effect of groove binding 
and intercalation.   
 
Figure 4.4: Threading intercalation:19 Circular dichroism of [Cu(Cur)(DIP)]Cl2 (11) indicating intercalation as the predominant 
mode of binding. 17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 
10 
a b c 
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4.3.2.2 Groove binding 
In the previous example, Curcumin was identified as a groove binder. Typically groove binders are 
crescent shaped molecules with several aromatic rings connected by bonds with torsional freedom. The 
overall helical structure of DNA has sections where the strands are close to each other, known as minor 
grooves (AT rich sequences), and sections where they are further apart, known as major grooves (GC rich 
sequences). Groove binding relies on steric geometrical factors of the complete molecule to interact with 
these grooves via van der Waals and/or hydrogen bonding and mainly inhibit protein interaction or induce 
slight structural rearrangement of the DNA helix.11 
Rajesh and co-workers20 studied the interaction of 12 and 13 with CT DNA via UV–Visible, 
fluorescence, circular dichroism (CD), cyclic voltammetry and gel electrophoresis methods. CD is a 
technique that investigates how the structure of DNA changes upon interaction with a compound. DNA in 
its most common B-form display 2 bands in CD, a positive band (around 275 nm) and a negative band 
(around 248 nm) due to the base stacking and the polynucleotide helicity, respectively.  
 
Figure 4.5: Circular Dichroism: Cu(Cur)(H2O)Cl (12) and [Cu(Cur)2] (13). 20 
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Their circular dichroism studies (Figure 4.5) showed strong perturbation of both the positive (base 
stacking) and negative (polynucleotide helicity) CD bands. The general decrease in the positive band and 
the new band forming in the negative band indicate the DNA is unwound upon addition of the complexes 
which destabilize the B-form DNA via groove binding.20  Rajesh et al.21 then synthesized macrocyclic 
tetraaza diacetyl curcumin Cu(II) complex (14) which also interacts with DNA via groove binding with a 
comparable binding constant, Kb = 1.4 × 105 M-1. 
 
Figure 4.6: Macrocyclic tetraaza diacetyl curcumin Cu(II) complex (14). 21 
4.3.2.3 Electrostatic binding 
Electrostatic binding is common for charged molecules. Some ligands form large aggregates (to reduce 
repulsion between ligands) with the anionic phosphonate backbone held in place by non-specific, outside 
edge stacking interactions. Arjmand et al.8 studied the DNA interaction of three novel dizinc (II) complexes 
and during UV-Vis absorption titrations observed a hyperchromic shift of the intraligand absorption band 
and a slight blue shift upon addition of CT DNA. The hyperchromism occurred as a result of DNA structural 
damage which they attribute to electrostatic interaction between their complexes and DNA. They suspected 
partial intercalation as a possible contributor to the electrostatic interaction observed.  
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Figure 4.7: Dizinc(II) complexes 1–3, derived from 1,2-bis(1H-benzimidazol-2-yl)ethane-1,2-diol 8 
4.4 Results and Discussion 
4.4.1 DNA binding studies 
Various analytical techniques are used to study drug-DNA interactions. These interactions can be 
monitored via Infra-red (IR), Raman, Circular dichromism (CD), UV-Vis, fluorescence and nuclear 
magnetic resonance (NMR) spectroscopies as well as through Atomic force microscopy (AFM), 
electrophoresis, mass spectrometry, viscosity measurements, thermal denaturation studies, and cyclic, 
square wave and differential voltammetry. Several review articles are available to enhance the 
understanding of the application of these methods for drug-DNA binding studies.11,20,22,23 However, only 
UV-Vis spectroscopy will be discussed further with regards to the preliminary DNA binding studies 
reported on in this chapter.   
Electronic absorption spectroscopy is a common technique used to study drug-DNA interactions. UV-
Vis titration experiments are commonly performed for preliminary confirmation of drug-DNA interaction. 
By simply monitoring the change in absorbance upon addition of either DNA or compound, a correlation 
can be made to the type of interaction occurring. A hyperchromic shift indicates a conformational change 
in the DNA that leads to destabilization of the secondary structure, whereas any stabilization causes a 
hypochromic shift. Essentially, the shift in the position of an absorbance maximum is monitored and a 
comparison is made between the absorbance of free compound and that of the compound-DNA complex.  
Stellenbosch University  https://scholar.sun.ac.za
UV-Vis DNA Binding Studies 
   115 
 
Compounds that interact via intercalation generally lead to a reduction in absorbance (hypochromism) 
accompanied by a shift to higher wavelength (bathochromism/ red shift).24 The π* orbitals of the aromatic 
chromophore can overlap with the π orbitals of DNA base pairs stabilizing the π-π* stacking interactions 
thus lowering the π-π* transition energies.25 Electrostatic interaction, usually between a charged compound 
and the phosphorous backbone, leads to hyperchromism. Groove binders can induce both hypo- and 
hyperchromism based on the effect that it exerts on the DNA structure.  
 
Figure 4.8: Non-covalent DNA binding modes. From left to right; intercalation, groove binding and electrostatic binding. 26 
4.4.1.1 Electronic absorption titration 
As previously mentioned, a common method to study the DNA binding is to monitor the absorbance 
during UV-Vis titrations. Ideally a wavelength where only the DNA or only the complex absorbs, should 
be monitored.27,28 However, in the current study the absorption bands of the compounds under investigation 
overlapped with those of DNA. Thus, an alternative method was employed where DNA was added to both 
the reference and the sample cuvettes. This method allows the direct correlation of any change in the 
compound spectrum to the interaction between the compound and DNA.29  
The DNA binding capability of D2, C1, MC1, L3, C4a, C4b and C5 was evaluated through UV-Vis 
absorption titrations. During the UV-Vis titrations the compound concentration was kept constant while 
varying the DNA concentration in solution. The change in absorbance correlates to drug-DNA interaction 
and can be employed to elucidate information about binding behaviour. The synthesis and characterization 
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of these compounds were discussed in Chapter 3, section 3.2. The compounds evaluated can be divided 
into phosphonic acid complexes (MC1 and C1) and salicylaldimine complexes (L3, C4, C5). The data 
presented in this chapter provides some insight with regards to the effect of the ligand (C1 vs C4) and the 
metal (C4 vs C5) on the compounds binding interaction with DNA.  
The preliminary UV-Vis titration studies for the phosphonic acid complexes (MC1 and C1) were 
hampered by the solubility of the compounds. The spectra recorded in DMSO showed negative absorption. 
It was thought that DMSO coordinates to the compound in solution, leading to a negative absorbance. Thus, 
a small test was performed where the compounds were dissolved in H2O before adding DMSO (5 × 10 µL) 
portions and allowing 10-minute incubation periods at 25 °C before collecting the corresponding UV-Vis 
spectra. All these absorptions remained unaltered after the DMSO interaction test which suggests solvent 
interaction was not the cause of the negative absorbance observed.  
The preliminary UV-Vis titrations (MC1 and C1) conducted in H2O showed a single absorption band 
in the range of 200 – 260 nm. These absorption bands can be attributed to amide n-π* transition. The 
experiment was inconclusive as the absorbance intensity varied randomly as the concentration of the DNA 
was added. In the case of MC1, an absorbance at 620 nm indicated that there were some particles in 
suspension. The lack of solubility and hygroscopic nature of MC1 and C1 prohibit the accurate 
determination of the weight, which influence the concentration of stock solutions. Thus, the phosphonic 
acid complexes could not be studied by UV-Vis spectroscopy. 
The UV-Vis binding studies of D2 in H2O displayed an absorbance at 294 nm which can most likely 
be attributed to the π-π* transition of the amide moiety. The band displays a slight hyperchromic shift upon 
addition of DNA and the formation of a new absorption band at 222 nm is also observed. Although this 
indicates some interaction, most likely via groove interaction, it is not significant when compared to the L3 
or C4a, C4b and C5. This is expected, otherwise it would not be worth modifying the dendrimers.  
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The UV-Vis binding studies (Figure 4.9) for L3 showed 4 absorption bands. The π-π* transition for 
L3 are observed at 212 and 255 nm. These differ from D2 and can be ascribed to the aromatic chromophore 
present in L3. Additionally, the imine n- π* transition is observed at 325 nm and the band in the region of 
350 – 400 nm are likely due to some intra ligand transition.  
 
Figure 4.9: UV-Vis titrations of L3 interacting with increasing concentration SS-DNA. 
 
The UV-Vis spectra of L3 show a hyperchromic effect of 9 % upon addition of DNA for ʎmax = 255 
nm. The ligand (L3), without any metal, is expected to interact with DNA. However, the hyperchromic 
shift observed for L3 contradicts the expected hypochromism commonly observed for Schiff-base ligands. 
The UV-Vis spectra of C4b (Figure 4.10) showed 5 absorption bands. The results are similar to that 
observed for L3, yet the hyperchromic effect was more pronounced with ʎmax = 255 nm showing 
hyperchromism of 28 %. These compounds most likely interact with DNA in an electrostatic or groove 
binding mode. Although, given the nature of these compounds, they are more likely to interact through 
groove binding that damage the DNA double helix, hence the hyperchromism. 
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Figure 4.10: UV-Vis titrations of C4b interacting with increasing concentration SS-DNA. 
On the contrary, C5 displays the expected hypochromic shift for all its corresponding absorptions, 
where ʎmax = 267 nm show 24 % hypochromism, and is likely due to the π-π* stacking interaction between 
the aromatic chromophore present in the ligand and the DNA base pairs. 
 
Figure 4.11: UV-Vis titrations of C5 interacting with increasing concentration SS-DNA. 
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Comparing C4a (Ga) and C5 (Cu), which is based on the same ligand, it is clear how crucial the metal 
centre is for the activity of the compound under investigation. By altering the metal the mode of binding is 
completely different.  
The preliminary DNA binding studies for C4a are presented in Figure 4.12 and 4.13. Figure 4.12 
displays the spectra obtained when adding increments of DNA to the compound solution, whereas Figure 
4.13 displays the spectra obtained for constant compound and DNA concentration monitored hourly for 24 
hours. The UV-Vis titrations studies for C4a showed 5 absorption bands. The absorption bands 
corresponding to the aromatic π-π* transition show a constant hypochromic shift. The shoulder at 280 nm 
disappeared and was accompanied by the formation of a new absorption band at 300 nm, which for the 
duration of the experiment displayed a hyperchromic shift. The imine n-π* transition as well as the band 
ranging from 380 – 400 nm initially indicated a hyperchromic shift before decreasing in absorption for the 
rest of the experiment. These observations, varying hyperchromism and hypochromism, preliminarily 
indicate the possibility that multiple modes of binding are present when C4a interacts with DNA.  
 
Figure 4.12: UV-Vis titrations of C4a interacting with increasing concentration SS-DNA. 
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Figure 4.13: UV-Vis titrations of C4a interacting with increasing concentration SS-DNA. 
 The shoulders appearing in the range of 280 – 300 nm can be due to the single strand of DNA 
liberated from the double helix-DNA strands. In other words, as the compound interacts with the DNA, 
double helix is divided to single strands which only increase in the vial containing the compound, thus only 
appearing after a while when the concentration is detectable. 
The manner in which the ligand binds to the metal center is also important. C4a and C4b consist of 
the same ligand (L3) and the same metal center (Ga), but differs only in the precursor used to obtain the 
respective complexes. There was clearly a different mode of binding at play with these metals and, although 
further studies have to be conducted to determine exactly what occurs, the metal surrounded by 2 dendritic 
branches most likely interact via groove binding and the metal surrounded by a single dendritic branch 
interacts via multiple modes of binding.  
4.5 Conclusion 
In this chapter, the preliminary UV-Vis binding studies of the cyclam-cored PAMAM dendrimer (D2), 
phosphonic acid derivatives (MC1 and C1), salicylaldimine ligand (L3) and complexes (C4a, C4b and C5) 
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was reported. D2 showed a slight hyperchromic shift that suggests the dendritic scaffold interacts via groove 
binding. The phosphonic derivatives were hampered by lack of solubility and could not be assessed by UV-
Vis binding studies. Surprisingly L3 and C4b showed hyperchromism with the latter being more apparent, 
which indicates either electrostatic or groove binding interaction is at play. The nature of these compounds 
is more likely to interact through groove binding that can damage the DNA double helix. C5 shows a 
hypochromic effect and is likely due to the π-π* stacking interaction between the aromatic chromophore 
present in the ligand and the DNA base pairs. C4a showed varying hyperchromism and hypochromism 
which suggests that it interacts with DNA via multiple binding modes.  
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4.6 Experimental Section 
A Tris-HCl buffer solution (pH 7.2) was prepared following a standard protocol. 200 μM stock 
solutions of each compound were prepared in H2O by stirring overnight. The stock solutions were diluted 
to 20 μM sample solution using Tris-HCl buffer solution (pH = 7.25). The corresponding reference sample 
(10 % H2O/Tris-HCl buffer) was prepared. The 160 µL DNA (1mg/ml) sample was dissolved in 9.9 ml 
Tris-HCl buffer at pH = 7.25. The concentration of SS-DNA was determined via UV-Vis spectrometry at 
A258 and was found to be 0.50 mM. The molar absorptivity value was taken as 6600 M-1 cm-1. A solution 
of the DNA in Tris-HCl buffer gave a ratio of UV-absorbance at 260 and 280 nm (A260/A280) of 1.8, 
indicating the DNA was sufficiently free of protein. All the stock solutions were stored at > 4 °C and used 
within four days.  
The UV-Vis titration spectra were recorded from 190 nm to 800 nm with fixed compound 
concentration while varying the SS-DNA concentration. Aliquots (5 – 20 μL) of salmon sperm DNA (0.46 
– 0.50 mM) were added to both the sample cell and the reference cell in order to eliminate the absorbance 
of SS-DNA itself. The samples were manually stirred before allowing 5-minute incubation time at 25 °C 
between each addition of DNA. At incubation temperature 37 °C, the DNA denatures. The process was 
repeated until the same spectrum was obtained for three additions of DNA, indicating that DNA saturation 
was achieved. 
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CONCLUSIONS AND FUTURE WORK 
The aim of this research project was to develop novel targeted dendritic radiopharmaceuticals which 
could potentially be applied in targeted radiotherapy. Careful consideration of the dendrimer scaffold, 
chelating ligand as well as the radionuclide was taken.  
The first objective was to synthesize novel cyclam-cored PAMAM dendrimers of various generations. 
The cyclic core was chosen to incorporate specific physical properties to the dendrimer scaffold. The 
divergent synthesis of these dendrimers was discussed in Chapter 2. We successfully synthesized G1 
cyclam-cored PAMAM dendrimer (D1 - D2), but could unfortunately not succeed in isolating the G2 
derivative (D3 - D4) due to several complications during the amidation reaction. Therefore, alternative 
TACN-cored PAMAM dendrimers (D5 - D6) was attempted via a similar method, but the difficulties in the 
amidation reaction persisted. We found that during the amidation reaction several side reactions yielded a 
mixture of products that remained inseparable due to the similarities of their chemical properties.  In a last 
attempt to obtain higher generation cyclam-cored dendrimers, we attempted to alter the branches. Cyclam 
dendrimers with propyl branches (D7 - D8) and cyclam dendrimers with benzyl branches (D9 - D10) was 
attempted in order to circumvent the amidation step. Unfortunately, we could not succeed in reducing the 
nitrile moieties completely to only their primary amine derivatives.  
At that point D2 was identified as a viable dendritic scaffold for two ranges of dendritic ligands. 
Initially, a phosphonic acid (L1) derivative was synthesized via an Irani-Moedritzer. As a comparison to 
L1, a range of phosphonic acid model ligands were also synthesized (L2, ML1, ML2). We found that 
during the synthesis of the phosphonic acid derivatives the amide moiety of the PAMAM dendrimer was 
susceptible to hydrolysis, which contributed to a mixture of products that was near impossible to separate. 
The nature of the crude products, especially in the case of L1, hindered the seemingly unreproducible 
reaction further. Alternatively, a salicylaldimine (L3) derivative was obtained via a Schiff base 
condensation reaction. The dendritic ligand synthesis was discussed in Chapter 3, which also covered the 
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complexation reactions with either gallium or copper to obtain “cold” dendritic radiopharmaceutical 
analogues. C1 and MC1 was obtained through complexation of gallium with L1 and ML1, respectively. 
L3 was modified with gallium (C4a and C4b) as well as copper (C5) to obtain their respective complexes. 
Where possible, all ligands and complexes were characterized by FTIR and NMR spectroscopy, elemental 
analysis, mass spectrometry and UV/Vis spectroscopy.  
Finally, the DNA binding studies of some of the dendritic complexes were preliminarily investigated 
via UV Vis spectroscopy titration reactions. The phosphonic acid derivatives were only partially soluble in 
the buffer solution and could therefore not be assessed via this technique. The salicylaldimine ligand (L3) 
as well as the gallium (C4a, C4b) and copper (C5) derivatives were viable candidates. The results indicated 
that all four compounds interacted with salmon sperm DNA. L3 and C4b showed hyperchromism which 
indicates either electrostatic or groove binding interaction is at play, but given the nature of these 
compounds, groove binding is more likely. C5 shows a hypochromic effect, which translates to intercalation 
as the mode of binding to DNA. C4a showed varying hyperchromism and hypochromism which suggests 
that it interacts with DNA via multiple binding modes. Further investigation of these compounds is 
necessary to draw a concrete conclusion as to their preferred mode of binding with DNA.  
To conclude, the benefit that the cyclic core would add to the topology of the dendrimer is not 
significant below generation 2 dendrimers and obtaining generation 2 and higher dendrimers of adequate 
purity was simply not feasible. Thus, if dendrimers were to be chosen as the nanocarrier vector, 
commercially available dendrimers would certainly be the way to go. Alternatively, the dendrimers could 
be synthesized via a convergent approach where the dendrons would be synthesized and isolated before 
linking them to a core Figure 5.1. This would enhance the purity of the dendrimers and grant the opportunity 
of obtaining higher generation dendrimers; however, this method is quite costly during synthesis.  
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Figure 5.1: Suggested convergent approach – Dendron growth followed by click chemistry to incorporate cyclic core. 
 
Following the Irani-Moedritzer procedure it was possible to synthesize the corresponding ligands; 
however, the purification and isolation of these ligands were hampered by the lack of solubility and range 
of products in the reaction mixture. The best solution was to add the appropriate gallium salt and isolate the 
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complex. The major concern during this approach was the stringent reaction conditions which could lead 
to amide hydrolysis, contributing to the product mixture. 
In the case of the Schiff base derivatives, it would be possible to perform the Schiff base condensation 
reaction directly with the mixture of products obtained from the full generation PAMAM dendrimers and 
isolating the corresponding salicylaldimine product. The aldehyde would only react with primary amines 
and the formed product should have significant different solubility than the byproducts. The Schiff base 
derivatives also offer the opportunity to incorporate a phosphonic acid moiety across the imine bond.  
The phosphorylation of imine bonds to yield the corresponding α – aminophosphonates via a Pudovik 
reaction is a common methodology employed. The corresponding α – aminophosphophonic acid could be 
isolated after hydrolysis. Acid catalysed hydrolysis1 requires high temperature, long reaction times and the 
use of strong hydracids (HCl, HBr, HI). Reagents that contain functional groups that are susceptible to 
hydrolysis limits the use of acids as catalysis. As an alternative base catalysed hydrolysis2,3 could be 
employed, but generally leads to incomplete hydrolysis i.e. monoesters. The use of halogen-trimethylsilanes 
as hydrolysis agent provide a means to overcome the limitation.3  
 
Figure 5.2: Acid- and Base catalysed hydrolysis of phosphonate esters. 
 
Thus, in order to advance this research, meticulous planning of all synthetic aspects should be done. 
This would allow us to harness the advantages that dendrimers offer and exploit them as scaffolds for 
targeted radiopharmaceuticals. 
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